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Abstract 
On antimicrobial approaches to arrest and control chronic 
periodontitis 
 
Maj-Karin Hellström 
Department of Periodontology, Institute of Odontology, The Sahlgrenska Academy  at the 
University of Gothenburg, Box 450, SE-405 30 Göteborg, Sweden  
 
The main objectives were to study the effect of frequently repeated supragingival plaque 
removal on the subgingival microbiota and periodontal pocket reduction and to analyze the 
adjunctive effect of different antimicrobial agents on the treatment of periodontal disease. 
Subjects with gingivitis or chronic periodontitis were included.  
The patients in Study I underwent professional supragingival removal of plaque and calculus 
2-3 times/week for 30 weeks. At sites with suprabony and infrabony pockets and furcation 
sites, repeated supragingival plaque removal reduced the total number of microorganisms, as 
well as the percentage of sites with P. gingivalis. 
 In Study II, six months of unsupervised use of a dentifrice containing 0.3% magnolia extract 
produced significantly less gingival inflammation than a corresponding control dentifrice. 
Furthermore, at sites with similar amounts of plaque, fewer signs of gingival inflammation 
were observed in the magnolia group than the control group. 
In Study III, the effect of topically applied PVP iodine used as an adjunct both during basic 
SRP and at re-treatment during long term-maintenance was studied. PVP iodine, applied 
topically during subgingival instrumentation, may improve the outcome of SRP therapy.  
In Study IV, the short- and long-term effects of the systemic administration of tetracycline in 
conjunction with SRP were studied. One year after active therapy, the probing attachment 
level in the test group was almost 3 times higher than in the control group.  Re-examinations 
after 3, 5 and 13 years of SPT disclosed that this short-term benefit was not maintained in the 
longer perspective.  
In Study V, the effects of topically applied minocycline in combination with surgery on PPD 
reduction were analyzed. Local minocycline as an adjunct to surgery produced a statistically 
significantly larger reduction in probing depth (0.3mm) compared with surgery alone. 
Key words: Plaque control, microorganisms, magnolia, dentifrice, gingivitis, PVP iodine, 
maintenance, tetracycline, minocycline 
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Abbreviations 
 
BL = baseline 
BoP = bleeding on probing 
CAL = clinical attachment level 
CHX = chlorhexidine 
GI = gingival index 
NS = non significant 
OHI = oral hygiene instructions 
PAL = probing attachment level 
PI = plaque index 
PPD = probing pocket depth 
QHI = Quigley and Hein Index (dental plaque) 
SD = standard deviation 
SPC = supportive periodontal care 
SPT = supportive periodontal therapy 
SRP = scaling and root planing 
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Introduction 
Gingivitis and periodontitis 
Most periodontal diseases are plaque-associated inflammatory disorders. 
Gingivitis and chronic periodontitis are the most commonly occurring forms of 
periodontal disease (Caton et al. 1999, Lindhe et al. 1999). It is well documented 
that chronic periodontitis starts as an inflammatory lesion in the gingiva which, 
if left untreated over time, may progress to involve and cause damage and the 
breakdown of smaller or larger parts of the periodontal attachment apparatus 
(e.g. Saxe et al. 1967, Lindhe et al. 1973, 1975, Page & Schroeder 1976). 
Findings from epidemiological studies indicate that the prevalence of subjects 
with gingivitis is already high among children and young adults, that the number 
of subjects with chronic periodontitis (i) increases with age and that (ii) > 50% 
of the population above the age of 50 years exhibit signs of periodontal tissue 
breakdown in one or more parts of the dentition (Scherp 1964, Hugoson & 
Jordan 1982, Okamoto et al. 1988). 
Gingivitis unequivocally develops in subjects with healthy gingiva who, during 
a 2-3 week period, refrain from tooth-cleaning (Löe et al. 1965) and thereby 
allow microorganisms to colonize the supragingival part of the tooth (Theilade 
et al. 1966). It is also well known that products released from this plaque or 
biofilm initiate a host defense (inflammation – gingivitis) that (i) effectively 
prevents bacteria from invading the host but also (ii) induces a series of local 
tissue alterations including the establishment of inflammatory cell infiltrates in 
the marginal gingiva (“initial” and “early lesions”; Page & Schroeder 1976). 
Concomitantly, parts of the junctional epithelium are lost and replaced with a 
“non-attached” pocket epithelium. A niche – a pocket – is hereby established 
between the tooth and the marginal soft tissue. The local environment is 
changed and a biofilm with a different bacterial composition may become 
established in this newly formed subgingival pocket compartment  (Socransky et 
al. 1998, Haffajee & Socransky 2005, Socransky & Haffajee 2005). In this shift, 
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the microbial population in the biofilm changes from “an endogen poly-
microbial opportunistic flora” (Dahlén & Frandsen 2002) in the supragingival 
location to become dominated in the subgingival setting by “gram-negative 
proteolytic and predominantly anaerobic” microorganisms (Dahlén 2009). The 
host response to this altered microbial challenge changes and an “established 
lesion” forms in the gingiva (Page & Schroeder 1976). The mechanisms 
involved in the transition of a gingival lesion into a more profound “advanced 
lesion” (Page & Schroeder 1976) that also involves the cementum, the 
periodontal ligament and the alveolar bone are currently not fully understood, 
but they are most probably related to the ability of the host to respond to the 
multitude of products that emanate from the biofilm. 
 
Studies in man and experiments in animals have shown that gingivitis lesions, as 
well as lesions of chronic periodontitis, may resolve, following treatment 
regimens that include the removal of supra- and subgingival plaque and (its 
mineralized component) calculus (e.g. Heitz-Mayfield et al. 2003). It has also 
been demonstrated that, following this basic therapy, recurrent disease can be 
prevented in most cases and sites in subjects who are enrolled in careful 
professional and self-performed supportive treatment programs (Supportive 
Periodontal Therapy; SPT), including the regular removal of supragingival 
biofilm (e.g. Axelsson & Lindhe, 1974, 1978, 1981a, b, Becker et al. 1984, 
Axelsson et al. 2004). 
The critical role of plaque in the etiology of gingivitis and chronic periodontitis 
was further evaluated in programs studying the effect of “preventive” measures 
delivered to schoolchildren and adults (Axelsson & Lindhe1974, Axelsson et al. 
1991, 2004). In the studies referred to here, panelists were recalled on a regular 
basis (1/2 weeks to 1/3-6 months) to the dental clinic for professional tooth 
cleaning and information, as well as training in self-performed tooth-cleaning 
measures. In subjects participating in these programs, most gingivitis was 
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resolved and the progressive tissue destruction in chronic periodontitis was 
prevented or arrested. 
 
The outcome of self-performed and/or professional supragingival 
plaque control 
The effect of supragingival plaque control on the subgingival biofilm and 
associated clinical symptoms of periodontal disease has been examined in both 
clinical and animal studies. In some of the studies, it was observed that the 
plaque control program had an obvious effect on the subgingival microbiota 
(e.g. Tagge et al. 1975, Siegrist & Kornmann 1982, Smulow et al. 1983, 
Katsanoulas et al. 1992, McNabb et al. 1992, Dahlén et al. 1992, Al-Yahfoufi et 
al. 1995, Haffajee et al. 2001), while no such influence could be found in other 
studies (e.g. Listgarten et al. 1978, Kho et al. 1985, Beltrami et al. 1987, Loos et 
al. 1988).  
Del Peloso Ribeiro et al. (2005) showed that there was a reduction in gingival 
inflammation after one session of professional supragingival plaque control.  
 
Clinical, histological and biochemical observations  
Tagge et al. (1975) reported on the clinical outcome of (i) subgingival root 
debridement and (ii) self-performed supragingival plaque control in patients 
with chronic periodontitis. In each of 22 subjects, 3 sites that exhibited a similar 
degree of inflammation, assessed by crevicular fluid measurements, were 
identified. Following a baseline examination, a gingival biopsy was obtained 
from one of these sites, while a second site was exposed to meticulous scaling 
and root planing. The third site was left without treatment. All the volunteers 
received instruction in the appropriate self-performed plaque control measures. 
After 2 months of self-performed supragingival plaque control the 2 
experimental sites were subjected to a clinical re-examination and biopsy. In the 
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biopsy material, the size and extent of the inflammatory lesions were 
determined. The results revealed that both treatments reduced inflammation and 
pocket depth, but also that the combined treatment (subgingival debridement 
plus supragingival cleaning) was more effective than supragingival plaque 
control alone.  
Del Peloso Ribeiro et al. (2005) investigated 25 patients with chronic 
periodontitis with at least 4 pockets of ? 5 mm. The patients underwent the 
extraction of hopeless teeth, the removal of plaque retention factors, instruction 
in good oral hygiene and a single episode of supragingival calculus and soft 
deposit removal, followed by self-performed oral hygiene for the following 21 
days. The results after 21 days showed an increase in the number of sites with a 
probing depth of ? 3 mm and a decrease in the number of sites with a probing 
depth of ? 6 mm. A change in the subgingival environment examined by 
measuring the level of trypsin-like enzymes (BAPNA test) produced by 
microorganisms like T. forsythensis, Treponema denticola and P. gingivalis 
showed a significant reduction compared with baseline values. 
  
Microbiological observations  
In an animal study in monkeys, Siegrist & Kornman (1982) investigated the 
effect of supragingival plaque control on the subgingival microbiota of 
experimentally (ligature) induced periodontitis lesions. Following a baseline 
examination, some sites were exposed to professional supragingival cleaning (3 
times a week for 6 weeks), while contralateral sites were left without cleaning. 
The re-examination revealed that the regularly repeated supragingival cleaning 
reduced (i) the total number of microorganisms and (ii) the percentage of black-
pigmented bacteroides species in the subgingival biofilm. 
Smulow et al. (1983) evaluated the effect of supragingival plaque control on the 
subgingival microbiota of deep (? 5 mm) pockets in 14 subjects with chronic 
periodontitis. In each subject, 4 sites were identified and they received different 
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therapies, i.e. (i) subgingival debridement alone (SRP), (ii) subgingival 
debridement plus professional cleaning 5 days/week for 3 weeks (SRP +SPT), 
(iii) SPT alone or (iv) no treatment. Bacterial samples were harvested prior to 
therapy and after 3 weeks. An analysis of the samples revealed that SPT alone 
was as effective as SRP + SPT in reducing the total number of colony forming 
units, as well as some anaerobic marker species.  
Similar findings were reported by McNabb et al. (1992) who treated and 
monitored subjects with initially poor oral hygiene and gingivitis. During the 
first 12-week period, only 2 of 4 quadrants of the dentition were treated by 
scaling and professional plaque control (3 times/week), while, during the 
second 12-week period, the remaining 2 quadrants were also included in the 
treatment regimen. It was observed that supragingival cleaning (i) markedly 
reduced the number of bacteria in the dento-gingival region and (ii) caused a 
relative increase in gram-positive microorganisms, while (iii) the numbers of P. 
gingivalis and spirochetes were decreased.  
Dahlén et al. (1992) studied the effect on the subgingival microbiota of a plaque 
control program that included supragingival scaling, repeated oral hygiene 
instruction and professional tooth cleaning during a 3-month period in subjects 
with moderately advanced chronic periodontitis. Sixty-two subjects and in these 
patients 134 sites were objected to both bacterial samples and clinical 
measurements obtained prior to therapy and after 2 years. The authors reported 
that the treatment resulted in (i) an increase in the number of sites with shallow 
pockets (? 3 mm), (ii) but no decrease in the number of sites with deep pockets 
(? 6 mm). Both in sites with shallow and remaining deep pockets, the 
supragingival therapy resulted in a biofilm with a markedly reduced bacterial 
density. Further, the number of subjects with samples positive for species such 
as A. actinomycetemcomitans, P. gingivalis and F. nucleatum was also markedly 
reduced between the baseline and the 2-year examinations.  
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Al-Yahfoufi et al. (1995) investigated the effect of the supragingival removal of 
calculus and soft deposits followed by self-performed plaque control in 10 
subjects with shallow pockets and without previous experience of periodontal 
treatment. All the patients displayed presence of P. gingivalis and P. intermedia. 
Further, A. actinomycetemcomitans were found in 5 of the subjects at the start of 
the investigation. After 1 month, the authors concluded not only that the clinical 
situation was improved but also that the number of subgingival bacteria was 
markedly reduced.  
Haffajee et al. (2001) reported that, as a consequence of self-performed plaque 
control measures, the composition of the subgingival microbiota associated with 
periodontitis was changed and the percentage of periodontopathic bacteria was 
reduced. 
Kho et al. (1985) studied the effect of self-performed supragingival plaque 
control on the subgingival microbiota in deep periodontal pockets in 8 subjects 
with chronic periodontitis. The clinical assessments were made on the Ramfjord 
Index teeth and 8 bacterial samples, one from each subject with a PPD of ? 7mm 
(mean PPD 8.2mm), were obtained at the 8- and 16-week re-examinations. The 
volunteers received surpragingival scaling and oral hygiene instructions (OHI). 
During 2 weeks of intense OHI, PlI and BoP decreased, but increased again 
during the period of self-performed plaque control. Thus re-examinations 
performed after 16 weeks revealed that there was (i) no improvement in 
gingivitis (BoP), (ii) no reduction in PPD and (iii) no change in the composition 
of the subgingval microbiota at sites with deep pockets.  
Similar findings were reported by Beltrami et al. (1987). Patients with deep 
periodontal pockets and vertical bone loss verified with X-rays in 2 pairs of 
contralateral sites were selected. They were given professional supragingival 
plaque control at some sites with deep pockets (mean PPD 6.8 mm) but no 
treatment at sites with a similar probing pocket depth. The professional cleaning 
of the test sites was repeated 3 times/week for 3 weeks. The patients maintained 
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their usual OH procedures including tooth brushing 1-2 times/day but without 
using interdental cleaning aids. Examinations, performed at baseline and after 3 
weeks, revealed that the treatment failed to reduce gingivitis scores and probing 
depths, as well as the numbers of different bacterial morphotypes in the 
subgingival biofilm.  
 Loos et al. (1988) studied the clinical and microbiological effects of a treatment 
program that included various forms of self-performed plaque control measures. 
Fifteen patients with untreated chronic periodontitis were recruited and 
subjected to clinical and microbiological examinations. During the study period, 
the patients were given OHI including the use of dental floss or tape, synthetic 
yarn and interdental brushes. The patients plaque control was checked weekly. 
After 6 weeks, in an attempt to improve OH, the patients were instructed to 
gently insert the tip of the Perio-Aid® (Marquis Dental MFG. Co., Aurora, CO, 
USA) below the gingival margin and to move the device intrasulcularly as deep 
as possible once a day. The patients were re-examined after 12 weeks. As a 
result of the large variation in OH, the initial group of 15 individuals was 
divided into 2 subgroups based on the level of plaque. Six subjects obtained Pl 
scores of ? 25%, while 9 subjects obtained plaque scores of < 25% at both 
examinations. The authors concluded that the effect of the various self-
performed plaque control regimens had no significantly different effect on 
clinical and microbiological parameters and failed to change the subgingival 
microbiota. 
 
Darkfield microscopy observations  
Listgarten et al. (1978) monitored 6 subjects with advanced chronic 
periodontitis. All the subjects received detailed instruction in proper self-
performed plaque control. In addition, meticulous scaling and root planing was 
performed in 2 quadrants of the dentition. Clinical and microbiological 
examinations were performed prior to therapy, as well as after 8 and 25 weeks 
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of treatment. The authors reported that, while the non-surgical therapy markedly 
affected the subgingival microbiota, self-performed plaque control measures 
failed to change the numbers of coocoid cells, motile rods and spirochetes. 
Katsanoulas et al. (1992) used a split-mouth design to study the effect of 
professional supragingival plaque control on the composition of the subgingival 
microflora. Thirteen subjects with untreated periodontal pockets of 4-6 mm 
received professional supragingival plaque control 3 times/week during a 
period of 21days in 2 test quadrants. The 2 remaining quadrants (control) were 
left without any professional supragingival plaque control. The subjects did not 
receive any oral hygiene instructions but were asked to brush their teeth once a 
day and not to use any interdental cleaning aids. Re-examination after 21 days 
showed a decrease in PlI scores at the test sites but no other clinical changes. 
The darkfield microscopy demonstrated significantly fewer spirochetes and 
motile rods compared with the control sites.  
 
In the majority of the studies demonstrating an effect by supragingival plaque 
control on the subgingival biofilm, it was observed that the plaque control 
program caused shrinkage of the gingiva and a reduced probing depth. As a 
result, it can be argued that the change in the subgingival microflora occurred 
subsequent to the occurrence of the reduced probing depth and that the 
supragingival environment per se did not have a direct influence on the 
subgingival flora. While supragingival plaque control may cause advanced soft 
tissue shrinkage at suprabony pockets, no significant change in the probing 
depth may occur at sites with infrabony pockets or pockets associated with 
furcation defects. The question of whether supragingival plaque control affects 
the subgingival biofilm should therefore be evaluated at sites with different bone 
morphology. 
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Mechanical debridement combined with periodontal surgery 
Several clinical studies have shown that the clinical outcome will improve, 
particularly in the case of deep periodontal pockets, if a surgical procedure is 
also performed. Heitz-Mayfield et al. (2002) reported the effect of surgical 
therapy, in a meta-analysis comprising 6 randomized controlled trials (Isidor et 
al. 1984, Lindhe et al. 1982, Lindhe & Nyman 1975, Philström et al. 1983, 
Ramfjord et al. 1987, Kahldahl et al. 1996). These 6 studies all had a split-
mouth design comparing non-surgical with surgical treatment in each patient. It 
was concluded that both treatment modalities are effective in the treatment of 
chronic periodontal disease. In shallow pockets, 1-3 mm, treated with open flap 
surgery, there was significantly more CAL loss compared with treatment with 
scaling and root planing. In medium-deep pockets, 4-6 mm, scaling and root 
planing showed significantly more CAL gain than treatment with open flap 
surgery. In pockets exceeding 6 mm, surgical therapy resulted in a significantly 
larger reduction in pocket depths and more clinical attachment gain than in 
corresponding pockets treated with scaling and root planing. 
From a randomized, single-blind, parallel-arm study comprising 64 patients, 
Serino et al. (2001) reported the short- and long-term results of non-surgical and 
surgical periodontal treatment during a period of 13 years. They reported that 
SRP during basic therapy (first year) reduced 75% of the category of deep 
pockets (?7mm) (28% to shallow pockets) compared with 92% in the surgery 
group (56% to shallow pockets). Furthermore, the numbers of shallow, medium 
and deep pockets were unchanged during the 12 years of maintenance. Four 
subjects (12.5%) in the surgery group and 8 subjects (25 %) in the SRP group 
displayed disease progression during the first 3 years of maintenance. The 
authors reported that, in subjects with advanced periodontal disease, surgical 
therapy produces better short- and long-term periodontal pocket reduction and 
added that this may lead to fewer subjects requiring additional adjunctive 
therapy. 
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Chemical plaque control  
Antiseptics 
The effectiveness of self-performed plaque control after a single oral hygiene 
instruction was reported not to be sufficient to resolve gingivitis in adults using 
a manual toothbrush (van der Weijden et al. 2005). The effectiveness of manual 
tooth brushing (van der Weijden 1998) and powered tooth brushing (Williams et 
al. 2004) on plaque removal, where the subjects performed their normal tooth 
brushing for 1 or 3 minutes, showed that approximately 61-69% of the initial 
amount of plaque still remained. These results are comparable with findings 
presented by Del la Rosa et al. (1979), who reported that subjects who had 
received oral hygiene prophylaxis and exercised self-performed tooth brushing 
daily for 28 days retained about 60% of the initial amount of dental plaque. 
Attempts have therefore been made to develop adjunctive means to improve the 
outcome of self-performed plaque control measures, by incorporating antiseptics 
in mouth rinses and toothpastes, for example (Lang & Brecx 1986, Axelsson & 
Lindhe, 1987, Svatun et al. 1989, 1990, 1993, DePaola et al. 1989, Deasy et al. 
1991, Lindhe et al. 1993, Addy 1995, Rosling et al. 1997a, b, Charles et al. 
2001, 2004, Davies et al. 2004, Stoeken et al. 2007).  
Antiseptic agents such as chlorhexidine, phenols, essential oils and cethyl 
pyridinium chloride as well as povidone iodine and metal salts like zinc chloride 
have been incorporated in mouth rinses and toothpastes (Addy & Moran 1997, 
2008). 
 
Effects of chlorhexidine, phenolic compounds and triclosan on plaque and 
gingivitis 
Since the early 1970s, chlorhexidine has been used as an adjunct in the 
prevention and treatment of periodontal disease. In a review, Fine (1995) 
reported that chlorhexidine rinsing resulted in a 48-61% plaque reduction 
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compared with 19-35% for essential oils and 0-30% for triclosan (a broad-
spectrum phenolic). The reduction in gingivitis was between 27-67% and 20-
75% for chlorhexidine and triclosan respectively, while essential oils reduced 
gingivitis by 15-37%. These results are in agreement with a number of clinical 
studies (e.g. Lindhe et al. 1993, Addy 1995, Rosling et al. 1997a, Charles et al. 
2001, 2004, Davies et al. 2004). 
Experimental in vitro studies have indicated that triclosan has anti-inflammatory 
properties that may in part explain its effect on gingivitis, despite the fairly 
mediocre effect on plaque (Creeth et al. 1993, Waaler et al. 1993, Barkvoll & 
Rölla 1994, 1995, Gaffar et al. 1990,1995, Kjaerheim et al. 1995, Mustafa et al. 
2005). It has been reported from in vitro studies that triclosan inhibits the release 
of prostaglandin E2 from IL-I?-stimulated gingival fibroblasts (Gaffar et al. 
1995, Mustafa et al. 2005). The level of IL-I? in the crevicular fluid from adults 
with periodontal breakdown has been found to be correlated to the degree of 
gingival inflammation (Wilton et al. 1992).  
To enhance the plaque-reducing effect, different antibacterial agents like co-
polymer (polyvinylmethyl ether and maleic acid; PVM/MA) or zinc citrate have 
been incorporated in toothpastes containing triclosan. Synergistic effects of the 
co-polymer, as well as an increase in the substantivity of triclosan, have been 
reported by Gaffar et al. (1990, 1995), Lindhe et al. (1993), Ramberg et al. 
(1995) and Sreenivasan & Gaffar (2008) and, in the case of zinc citrate, by 
Svatun et al. (1989a, b, 1990, 1993). 
Lindhe and co-workers (1993) reported that, in subjects with gingivitis, the 
regular use of a triclosan-containing dentifrice significantly reduced gingivitis 
beyond what could be explained by the concomitant reduction of plaque per se. 
The authors reported that, at surfaces with similar amounts of plaque, fewer 
clinical signs of inflammation were observed in the triclosan group than in the 
control group.  
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An extract from the magnolia tree has been used for centuries in oriental 
medicine, mainly in China, Japan and Korea. The extract originates primarily 
from the magnolia tree (Magnolia officinalis) and the main source is the dried 
stem, root or branch bark (Chang & But, 1986). In addition to being used in 
traditional medicine to treat depression, anxiety, gastrointestinal disturbances, 
fever, muscular pain and headaches, the extract has been incorporated in dietary 
supplements and topically applied cosmetic products (Hattori et al. 1986, Tsai et 
al. 1992, Ogata et al. 1997, Sarker 1997, Hsieh et al. 1998, Maruyma et al. 
1998). 
Chemical investigations of the cortex of the magnolia tree have led to the 
isolation of several phenolic compounds, such as magnolol, isomagnolol and 
honokiol, among others (Fujita et al. 1972). The two main active components 
are magnolol and honokiol and the antibacterial and anti-inflammatory effects 
originate from these two major phenolic compounds. Magnolol has been shown 
to be the most active component and positive results in terms of inhibiting tumor 
metastases have been reported in both in vitro and in vivo studies (Nagase et al. 
2002, Ikeda et al. 2003). From experimental studies, it has been indicated that 
mangnolol, probably via its anti-oxidative effects, is able to prevent athero-
sclerotic vascular diseases (Ou et al. 2007). The anti-inflammatory and anti-
oxidant properties of the magnolia extract have been investigated by Wang et al. 
(1992, 1993), Lo et al. (1994) and Chen et al. (2006). Chen et al. (2006) showed 
that magnolol suppressed the IL-6-induced activity of intracellular cell-adhesion 
molecules (ICAM-1). Antibacterial effects by the magnolia extract have been 
reported by Ito et al. (1982), Lo et al. (1994), Park et al. (2004) and Chang et al. 
(1998), Ho et al. (2001). 
Experimental in vitro results indicate that magnolol and honokiol have 
significant antimicrobial activity against P. gingivalis, P. intermedia and A. 
actinomycetemcomitans, for example, even if the antimicrobial effect is lower 
than that produced by chlorhexidine (Chang et al. 1998). The authors suggested 
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“that magnolol and honokiol may have potential therapeutic use as a safe oral 
antiseptic for the prevention and treatment of periodontal disease”. There are 
also reports stating that magnolia extract has an effect on fungi (Ito et al. 1982, 
Bang et al. 2000).  
There are reasons to suggest that the adjunctive effect of antibacterial and anti-
inflammatory agents may be helpful in resolving inflammatory lesions of the 
gingiva in subjects highly susceptible to periodontal pathogens, or in subjects 
unable to perform optimal plaque control. 
 
Adjunctive effect of antiseptics and antibiotics in conjunction with 
non-surgical and surgical periodontal therapy 
Scaling and root planing may be performed either as a “closed” procedure – 
non-surgical periodontal therapy – or after surgical exposure of the root surface 
– surgical periodontal  therapy. In a number of clinical trials, it was shown that 
both procedures, properly executed, might result in periodontal health (Ramfjord 
et al. 1973, 1987, Badersten et al. 1981, 1984, 1987a, b, Westfelt et al. 1985). 
Mechanical root debridement is a therapy that is technically demanding and, 
when performed at sites with deep periodontal pockets, varying amounts of 
plaque (and calculus) may be left behind (Waerhaug 1978, Caffesse et al. 1986, 
Matia et al. 1986, Buchanan & Robertson 1987). As a result, associated 
periodontal lesions may not heal properly following basic therapy (Badersten et 
al. 1981, 1984, Caffesse et al. 1986, Rosling et al. 2001) or recurrence of disease 
– due to de novo bacterial proliferation – may occur during the phase of 
supportive periodontal therapy (Magnusson et al. 1984). A further analysis of 
some of these studies reveals PAL loss of ? 1.5 mm in 5-10% of sites after 24-
42 months. To enhance the outcome of mainly non-surgical periodontal 
therapy, antiseptics (e.g. chlorhexidine, PVP iodine, phenolic compounds) and 
antibiotics (e.g. tetracyclines, amoxicillin, metronidazole) have been used, either 
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applied topically or delivered via the systemic route, as adjuncts to scaling and 
root planning (Goodson et al. 1979, Lindhe et al. 1979, 1983, Rosling et al. 
1986, Wennström et al. 1987, Rams & Slots 1996, Soskolne et al. 1997, 
Furuichi et al. 1997, Berglundh et al. 1998, van Winkelhoff et al. 1996). The 
results of these studies are, however, inconclusive. Some studies have 
demonstrated benefits from the adjunctive therapy on treatment outcome, while 
some investigators failed to demonstrate any improvement (for reviews see 
Mombelli & van Winkelhoff 1997, Tonetti 1997, Wennström 1997, Quirynen et 
al. 2002, Slots & Ting 2002, Herrera et al. 2008). 
 
The adjunctive effect of PVP iodine 
The natural element, iodine, was discovered in 1811 by the chemist Bernhard 
Courtois, but it was not until iodine was detoxified by chemical binding to 
macromolecules that this effective microbicide could be used without adverse 
reactions in human tissue. Free molecules of iodine may have an allergic effect, 
but, by combining molecular iodine and a surface tension lowering agent, i.e. 
polyvinyl- pyrrolidone (PVP iodine), the antimicrobial effect remains without 
causing any adverse events. Furthermore, the reduced surface tension of PVP 
iodine increases the ability of iodine to reach irregularities in the contaminated 
root surfaces (Gordon et al. 1993, Fleisher et al. 1997). 
Elemental iodine and its iodophor (PVP iodine, i.e. iodine + polyvinyl-
pyrrolidone) are broad-spectrum antiseptics that, upon direct contact, effectively 
kill both bacteria and yeast (Caufield et al. 1987). Furthermore, it was 
demonstrated that the water-soluble iodophor is cidal to both gram-positive and 
gram-negative bacteria, fungi, mycobacteria and viruses (Schreier et al. 1997, 
Kawana et al. 1997) and that PVP iodine kills periodontitis-associated 
microorganisms (Caufield et al. 1987, Higashiutsumi et al. 1993). It has also 
been reported that resistance to antiseptics and antibiotics does not influence the 
sensitivity of bacteria to PVP iodine (Kunisada et al. 1997, Michel & Zach 
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1997). On the other hand, bacterial resistance has not been reported following 
either short- or long-term exposure to PVP iodine (Gordon 1993, Lanker-
Klossner et al. 1997). 
Allergic and toxic reactions to PVP iodine are rarely reported (Neidner 1997). 
However, it should not to be used in subjects allergic to iodine or in pregnant or 
nursing women. Furthermore, PVP-iodine rinses can have an adverse effect on 
thyroid function (Ferguson et al. 1978, Nobukunu et al. 1997, Greenstein 1999).  
 
PVP-iodine mouth rinse  
Clark et al. (1989) tested 5% PVP iodine and 1.5% hydrogen peroxide in 
patients with chronic gingivitis as an adjunct to their standard oral hygiene. The 
subjects rinsed 3 times a day for 24 weeks and were irrigated subgingivally with 
5% PVP iodine and 1.5% hydrogen peroxide every 3 weeks during this time 
period. The patients showed significantly reduced gingival inflammation 
compared with the control rinse (water).  
Maruniak et al. (1992) reported that rinsing with 5% PVP iodine and 1.5% 
hydrogen peroxide (Perimed®) was effective in reducing plaque and gingivitis in 
subjects who, during a 2-week period, abstained from mechanical tooth 
cleaning. Seventy-one subjects were asked to rinse with Listerine®, Perimed®, 
Peridex® (0.2% chlorhexidine) or plain water. After 14 days, the papillary 
bleeding index (PBS) was significantly lower in the subjects who rinsed with 
either   Perimed® or Peridex® compared with Listerine® and water. 
PVP iodine applied topically in the dentogingival region may also reduce 
bacteremia following surgical procedures in the oral cavity (Rahn et al. 1993, 
1995, Dajani et al. 1997, Fleischer & Reimer 1997, Cherry et al. 2007). Rahn et 
al. (1995) irrigated the gingival sulcus before surgical tooth extraction with 10% 
PVP iodine and compared this effect with 0.2% chlorhexidine or only water in 
40 patients. The frequency of observed bacteremia after surgery was 27.5% for 
PVP-I, 45% for 0.2% chlorhexidine irrigation and 52.5% for water. 
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PVP iodine delivered with an ultrasonic scaler  
In a split-mouth design, Rosling et al. (1986) studied the effect of 0.5% PVP 
iodine administered through the cooling system of an ultrasonic scaler as an 
adjunct to periodontal therapy. They observed that there was more gain in 
clinical attachment at sites with deep pockets that were irrigated with PVP 
iodine than at sites that were irrigated with saline.  
This finding was confirmed by Christersson et al. (1988) who, in a similar trial, 
demonstrated that irrigating periodontal pockets with PVP iodine as an adjunct 
to non-surgical periodontal therapy resulted in more sites with attachment gain 
of ? 2 mm (80% of all sites) than a corresponding regimen using saline as the 
irrigating substance (55% of sites).  
Forabosco et al. (1996) used 0.5% PVP iodine with an ultrasonic scaler as an 
adjunct to surgical and non-surgical treatment in patients with chronic 
periodontitis using a split-mouth design. Twelve months after therapy, they 
reported that, at sites with initially deep pockets, PVP-iodine application 
resulted in better healing outcome than at sites not exposed to antimicrobial 
irrigation. 
Clinical and/or microbiological effect of PVP iodine  
In a split-mouth design including 16 adult subjects with at least 1 pocket of ? 6 
mm, Hoang et al. (2003) investigated the effect of (i) subgingival flushing with 
10% PVP iodine during 5 minutes in conjunction to SRP, (ii) SRP alone, (iii) 
flushing with 10% PVP iodine alone for 5 minutes or (iv) flushing with sterile 
saline for 5 minutes. All the patients had received appropriate OH instructions 
prior to the experimental phase.  
Clinical and microbiological examinations were performed at baseline and 5 
weeks post treatment. The microbiological results showed that subgingival 
irrigation with 10% PVP iodine for 5 minutes in conjunction with SRP resulted 
in a 95% reduction in the number of pathogens in 43.8% of the study sites, 
 21 
whereas the three other groups showed similar reductions in only 6.3% to 12.5% 
of the study sites. 
In a split-mouth designed study, Leonardt at al. (2006) evaluated the adjunctive 
effect of 0.5% PVP-iodine solution in conjunction with ultrasonic scaling. 
Twenty patients received one of four randomly distributed treatments: (i) 
ultrasonic scaling combined with either 0.5% PVP-iodine solution or saline in 
two quadrants and (ii) irrigation alone with saline or PVP iodine in the other two 
quadrants. The clinical evaluation was performed in one single-rooted 
tooth/quadrant with an initial PPD of ? 6mm. The 6-month evaluation revealed 
no differences in the reduction of PPD in the teeth subjected to ultrasonic 
scaling and irrigation with either PVP iodine or saline. The quadrants subjected 
to ultrasonic scaling with or without 0.5% PVP-iodine solution showed a 
significant reduction in both PPD and BoP, but the two treatment modalities 
were not significantly different. The results of the microbiological examination 
(Leonhardt et al. 2007) showed a reduction in periodontal pathogens by 
ultrasonic scaling but with no adjunctive effect from PVP iodine.  
During a period of 6 months, Grossi et al. (1997) investigated 115 subjects with 
periodontal disease and non-insulin-dependent diabetes mellitus. The subjects 
were divided into 5 treatment groups. All the participants received ultrasonic 
scaling and the patients in treatment groups 1, 2 and 3 also received systemic 
doxycycline, 100 mg/day for 2 weeks. Moreover, in the patients in group 2, the 
water used as a cooling agent during the ultrasonic scaling was replaced with 
0.12% chlorhexidine. For the patients in group 3, the cooling agent was replaced 
with 0.5% PVP iodine. The patients in group 4 received additional subgingival 
irrigation with 0.12% chlorhexidine, while the subjects in group 5 received only 
ultrasonic scaling with water. The results indicated that the subjects that 
received ultrasonic scaling in combination with systemic doxycycline 
experienced a greater PPD reduction and a greater reduction in subgingival 
microbiota than the corresponding subjects that had not been treated with 
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doxycycline (groups 4 and 5). It was concluded that the outcome of periodontal 
therapy including ultrasonic scaling combined with systemic doxycycline did 
not produce any additional effect when combined with the local application of 
CHX or PVP iodine in the cooling water. 
 
In most studies, PVP iodine appears to be a potent antimicrobial agent that can 
be used as an adjunct to mechanical instrumentation in the treatment of 
periodontitis. 
 
The effect of tetracyclines as an adjunct to non-surgical treatment 
in patients with periodontal disease  
Tetracycline and the analogs doxycycline and minocycline are broad-spectrum 
antibiotics which are effective against both aerobic and anaerobic bacteria, 
gram-positive as well as gram-negative. Tetracyclines are bacteriostatic at 
clinically achieved concentrations (Schnappinger & Hillen 1996). Antimicrobial 
agents used systemically are transported by the bloodstream and reach the site of 
periodontal infection and the target, the microbes, in the subgingival biofilm via 
the crevicular fluid, but they simultaneously also enter the saliva, other tissues 
and different body components (van Winkelhoff et al. 1996). Tetracycline and 
analogs to tetracyclines (i) inhibit bacterial protein synthesis (Maxwell 1968) 
and (ii) cause damage to the cytoplasmic membrane of the bacterial cell. The 
long-term use of tetracyclines may favor the development of resistant strains of 
periodontal bacteria (Kornmann & Karl 1982, Lacroix & Walker 1995). 
Tetracyclines, administered via the systemic route, have been used in clinical 
studies in patients with both aggressive periodontitis and chronic periodontitis as 
an adjunct to mechanical debridement. To have a synergistic effect in 
combination with the mechanical therapy, the antibiotics have to reach the 
microbiota in the biofilm at concentrations high enough to have a bacteriostatic 
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effect. It has been suggested that the microbiota living in biofilms could be 
1000-1500 times more resistant to antibiotics than planctonic living cells (Marsh 
2005). Other theories based on findings from scanning electron microscopy and 
laser confocal microscopy of in vitro cultured biofilms suggest that the channels 
found in the biofilm for the transportation of nutrients and waste products are 
thought to be sufficiently wide for the relatively small molecular size of most 
antibiotics (< 500 MW) to diffuse through these channels. Other theories state 
that antibiotics may adhere to extracellular products in the biofilm matrix, i.e. 
the glycolax, which will reduce or even inactivate the action of the antibiotic 
(Costerton et al. 1981, 1995). The view that the microbiota in a biofilm is more 
resistant to antibiotics is the subject of debate. Marsh (2005) concluded that new 
research about dental biofilms reveals properties that are typical of biofilms and 
microbial communities in general and a clinical consequence would therefore be 
reduced susceptibility to antimicrobial agents. Observations that tetracycline 
may reduce the collagenase activity in the inflammatory connective tissue and 
inhibit osteoclast activity have been reported by Vernillo and coworkers (1994). 
Tetracyclines and other antibiotics administered in doses that are too low to kill 
the microorganisms or the overuse of antibiotics can develop microbial 
resistance (van Winkelhoff et al. 2000). The risk of antibiotics inducing the 
development of resistant strains means that antibiotics should not be used 
routinely without a correct periodontal diagnosis and only in individuals with 
defined periodontal conditions (Herrera et al. 2008, Lindhe & Palmer 2002). 
The consensus report of the sixth European workshop on periodontology 
indicated that, if systemic antibiotics are part of the periodontal therapy, they 
should be adjunctive to mechanical debridement (Herrera et al. 2008). It was 
suggested and concluded that optimal conditions, i.e. mechanical supra- and 
subgingival debridement, of higher quality, produced a better result from the 
adjunctive systemic antibiotic treatment and that the time between the SRP and 
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the antibiotic intake was important and should be reduced to a minimum, in 
order to avoid biofilms rebuilding and reorganizing (Sanz & Teugel 2008). 
Studies have documented that a regimen of 250 mg of tetracycline HCL given 4 
times a day improved the resolution of gingivitis and promoted a gain in clinical 
attachment in patients with aggressive periodontitis, as adjuncts to mechanical 
debridement (Genco et al. 1981, Lindhe & Liljenberg 1984, Novak et al. 1988, 
1991). Analogs of tetracycline, such as minocycline and doxycycline, used as 
adjuncts in the treatment of chronic periodontitis, resulted in the same degree of 
healing as tetracycline, but the effect of the drugs on treatment outcome have 
varied (e.g. Williams et al. 1979, Ciancio et al. 1982, Müller et al. 1993a, b, 
Freeman et al. 1992, Loesche et al. 1996, Akincibay et al. 2008).  
 
Systemically administered tetracyclines as an adjunct to mechanical therapy in 
the treatment of chronic periodontitis 
 Listgarten et al. (1978) and Helldén et al. (1979) reported that systemic 
tetracycline used as an adjunct to scaling and root planing had no significant 
effect on treatment outcome. 
Lindhe et al. (1983) combined an initial standard dose of tetracycline HCL with 
a subsequent dose regimen of 250 mg/day for 1 year in the treatment of 14 
patients with chronic periodontitis. The authors reported that this type of 
tetracycline administration used in combination with mechanical therapy 
improved clinical parameters and reduced motile bacteria more than SRP alone.  
In most studies, systemically administered tetracyclines used in conjunction 
with mechanical debridement appear to have a short-term beneficial effect in the 
treatment of periodontitis. 
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Topically administered tetracyclines (doxycycline, minocycline) as adjuncts to 
mechanical therapy in the treatment of chronic periodontitis 
Even if the  therapy modalities that are currently available are effective, a great 
deal of interest has been focused on using antibiotic formulations administered 
locally in periodontal pockets, either as a single therapy, or in combination with 
non-surgical periodontal treatment (MacAlpine et al. 1985, Heijl et al. 1991, 
Garret et al. 1999, Wennström et al. 2001, Williams et al. 2001, Aimetti et al. 
2004, McColl et al. 2006). The effect of topically applied antibiotics in 
conjunction with surgery has been reported by a few investigators, i.e. Palmer et 
al. (1996) and Needlemann et al. (2000). 
Topically applied antibiotics in patients with periodontal disease used as an 
adjunct to conventional treatment are thought to reach the site of action in the 
subgingival biofilm. Goodson (1989) suggested that it is possible to maintain an 
adequate concentration of a topically applied antibiotic to promote antimicrobial 
effects.  
Different strategies in the local administration of tetracyclines have been 
developed for several decades. During the 1980s and early 1990s, results were 
published from studies in which tetracycline was combined with irrigation 
(MacAlpine et al. 1985, Silverstein et al. 1988, Nylund & Egelberg 1990, 
Christersson et al. 1993), followed by publications in which ethylene vinyl 
acetate fibers loaded with tetracycline were used (Goodson et al. 1991a, b,  
Newman et al. 1994, Drisko et al. 1995, Aimetti et al. 2004). The difficulties 
and time-consuming procedure involved in the placement of the tetracycline 
fibers in the pockets resulted in the development and use of minocycline and 
doxycycline in ointments and gels, as well as resorbable polymers which could 
easily be administered subgingivally (Garrett et al. 1999, van Steenberghe et al. 
1999, Walker et al. 2000, Wennström et al. 2001, Williams et al. 2001, 
Meinberg et al. 2002, McColl et al. 2006). Walker et al. (2000) examined the 
microbiota in 23 patients after treatment with topical applications of a gel 
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containing 8.5% doxycycline. Questions had been raised about whether high 
concentrations of locally applied antibiotics eliminate or suppress the normal 
“beneficial” flora and create an opportunity for colonization by microorganisms 
that are pathologically resistant either to doxycycline or to other related 
antibiotics. The patients in the test group received topically applied gel 
containing 8.5% doxycycline at baseline and the control group received 
instruction in good oral hygiene, but no SRP was performed in either of the 
groups. Subgingival plaque sampling was performed at baseline and after 1, 3 
and 26 weeks. The authors concluded that doxycycline treatment significantly 
reduced the anaerobic flora in subgingival plaque but did not result in a change 
in either the number of resistant bacteria or the overgrowth of fungi, for 
example.   
In a 6-month multicenter trial, Wennström et al. (2001) examined the effect of 2 
different non-surgical treatment approaches to chronic periodontitis, both 
involving the use of a locally delivered doxycycline. One hundred and five adult 
patients with at least 8 periodontal sites in 2 quadrants with PPD of ? 5 mm 
were randomly assigned to one of two treatment groups: scaling/root planing 
(SRP) with local analgesia or supra- and subgingival ultrasonic instrumentation 
without analgesia (“debridement”). The “SRP” group underwent a single 
episode of full-mouth supra-/subgingival scaling and root planing under local 
analgesia and, at the 3-month recall visit, full-mouth supra-/subgingival 
debridement with ultrasonic instrumentation was administered. In addition, 
8.5% doxycycline gel was administered at sites with a remaining PPD of ? 5 
mm. The subjects in the “debridement” group were treated for 45 minutes with 
ultrasonic instrumentation and the application of doxycycline gel at sites with 
PPD of ? 5 mm. At the 6-month examination, no statistically significant 
differences in PPD or CAL were found between the two treatment groups. The 
mean total treatment time for the “SRP” group was 3.11 hours, compared with 
2.00 hours for the patients in the “debridement” group (p<0.001). The authors 
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concluded that “simplified subgingival instrumentation combined with local 
application of doxycycline in deep periodontal sites can be considered as a 
justified approach for non-surgical treatment of chronic periodontitis”. 
Williams et al. (2001) examined the adjunctive effect of minocycline 
microspheres and SRP from an 18-center study. Three parallel groups, a total of 
748 patients at baseline, received treatment with (i) SRP (Control I), (ii) SRP 
plus placebo vehicle (Control II) or (iii) SRP and 2% minocycline in a 
microsphere vehicle (Test). At the 9-month re-examination, the subjects in the 
test group showed a mean reduction of 1.32 mm in pockets of ? 5 mm at 
baseline, with 1.08 mm in corresponding pockets in the control group. The mean 
difference between the test and control group was 0.24 mm (p<0.001). The 
authors concluded that SRP plus minocycline microspheres was more effective 
than SRP in reducing probing depths in periodontitis patients 
Van Steenberghe et al. (1999) presented clinical and microbiological 
observations from a multicenter study comprising 93 patients with moderate to 
severe periodontitis in which all the subjects received supra- and subgingival 
debridement at baseline, 6 and 12 months.  
In addition, the patients in the test group (46) received adjunctive treatment with 
2% minocycline ointment. At 2 weeks and 3, 6 and 12 months, all the subjects 
were instructed in normal oral hygiene measures and were asked to practice self-
performed oral hygiene. After 15 months, pockets with an initial depth of ? 
5mm in the test group showed a significant improvement after subgingival 
instrumentation (PPD reduction 1.9 versus 1.2 mm and PAL gain 0.9 versus 0.5 
mm). The microbiological results showed that P. gingivalis, P. intermedia and 
C. rectus were significantly reduced in the test group. For A. 
actinomycetemcomitans, no significant differences could be seen between the 
test and control group.  
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Topically administered minocycline during supportive periodontal treatment in 
patients with chronic periodontitis 
Meinberg et al. (2002) monitored 48 patients during a 12-month period of SPT 
who had been treated with conventional non-surgical debridement for moderate 
to advanced chronic periodontal disease. The patients were randomly assigned 
to 2 treatment groups in which SPT treatment in the control group was 
performed with subgingival debridement in all pockets with BoP and a pocket 
depth of ? 5 mm. In 24 subjects assigned to the test group, the subgingival 
application of 1 mg minocycline microspheres (Arestin®, Oral Pharma Inc., 
Warminster, PA, USA) was repeated at 1, 3 and 6 months in all pockets with 
BoP and a pocket depth of ? 5 mm, but without concomitant subgingival 
instrumentation. At the 1-months re-examination of the patients in the test 
group, an additional PPD reduction of 0.5mm was demonstrated compared with 
the control group. 
McColl et al. (2006) treated residual pockets in 40 patients with BoP and PPD of 
? 5mm for one year. The test group (20 subjects) received 2% minocycline gel 
subgingivally every 3 months and, at the same intervals, the subjects in the 
control group were treated with subgingival mechanical debridement. The 
plaque control was checked and, if necessary, reinforced. Clinical and 
microbiological examinations performed every 3 months in both groups showed 
a reduction in the numbers of sites with PPD of ? 5mm at the 3-month re-
examination, a reduction that was maintained during the study period. There 
were no statistically significant differences between the groups at any 
examination interval. The TVC increased during the 12-month period in both 
groups, but the increase was more pronounced in the SRP group for P. 
gingivalis, T. forsythus and T. denticola from 6 months on. 
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In most studies, there appeared to be a short-term beneficial effect from locally 
administered antibiotics (tetracyclines) used in conjunction with mechanical 
debridement in the treatment of periodontitis.  
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Summary of studies included in the present thesis.  
Objectives 
The aims of the present series of studies performed in patients with gingivitis 
and chronic periodontitis were: 
 
To assess the effect of frequently repeated supragingival plaque removal on 
the subgingival microbiota at periodontal sites with suprabony, infrabony and 
furcation lesions in patients with chronic periodontitis (Study I) 
  
To assess the effect of a dentifrice containing 0.3% magnolia extract in 
gingivitis patients on dental plaque and gingivitis (Study II)  
 
To assess the effect of topically applied PVP iodine in patients with chronic 
periodontitis, used as an adjunct during both basic non-surgical therapy and 
long-term supportive periodontal therapy (Study III)  
 
To study the short- and long-term effect of the systemic administration of 
tetracycline in conjunction with non-surgical treatment in patients with 
advanced chronic periodontitis (Study IV)  
 
To assess the effect of topically applied minocycline microspheres as an 
adjunct to surgical periodontal treatment in patients with moderate to 
advanced chronic periodontitis (Study V)  
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Study duration 
Study I: 30 weeks      
Studies II & V: 6 months 
Studies III & IV:  13 years   
 
Clinical examinations 
The following clinical parameters were assessed in all teeth except the third 
molars (Studies I, II & IV) and in all available non-molar teeth (Studies III & 
V). 
 
Dental plaque 
The amount of dental plaque was assessed after staining with a disclosing 
solution, erythrosin (Diaplac®, Wallco AB, Enköping, Sweden), on 4 surfaces 
(distal, buccal, mesial, buccal) per tooth (Studies I, III, IV & V) as 
present/absent (Ainamo & Bay 1976). Furthermore, in Study I on selected sites 
the dental plaque was assessed on 4 surfaces according to the criteria of the PlI 
(Silness & Löe 1964). In Study II plaque was assessed on 6 surfaces (disto,-
buccal, buccal,mesio buccal, disto-lingual, lingual, mesio-lingual) according to 
the criteria of the Turesky modification of the QHI Index (Quigley & Hein 
Index System; Quigley  and  Hein, 1962, Turesky et al. 1971).  
 
Criteria according to the Plaque Index (PlI) (Silness & Löe 1964) 
Score 0: no plaque 
Score 1: a film of plaque adhering to the free gingival margin and adjacent 
area of the tooth. The plaque may be seen in situ only after the application of 
disclosing solution or by using the probe on the tooth surface.  
Score 2: moderate accumulation of soft deposits within the gingival pocket, 
or on the tooth and gingival margin, which can be seen with the naked eye. 
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Score 3: abundance of soft matter within the gingival pocket and/or on the 
tooth and gingival margin. 
 
Criteria according to the Turesky modification of the Quigley and Hein 
Index (QHI) (Quigley and Hein, 1962, Turesky et al. 1971) 
Score 0: no plaque  
Score 1: separate flecks of plaque at the cervical margin of the tooth 
Score 2: a thin continuous band of plaque (up to one mm) at the cervical 
margin of the tooth 
Score 3: a band of plaque wider than one mm but covering less than one-
third of the crown of the tooth 
Score 4: plaque covering at least one-third of the crown of the tooth but less 
than two-thirds of the crown of the tooth  
Score 5: plaque covering two-thirds or more of the crown of the tooth 
 
Gingival inflammation 
The degree of inflammation was assessed at 4 sites per tooth according to the 
criteria specified in the Gingival Index System (GI) (Löe 1967) (Study I, 
selected sites, and Study II). 
 
Criteria according to the Gingival Index (GI) (Löe 1967)  
Score 0: absence of inflammation 
Score 1: mild inflammation – slight change in color and little change in 
texture  
Score 2: moderate inflammation – moderate glazing, redness, edema and 
hypertrophy; bleeding on probing 
Score 3: severe inflammation – marked redness and hypertrophy; tendency 
towards spontaneous bleeding 
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Pocket depth (PD) was assessed at 4 sites/tooth (distal, buccal, mesial, lingual) 
from the free gingival margin to the base of the pocket using a periodontal probe 
(Hu-Friedy, GF-W, USA) to the nearest 1 mm (Study I) or at 6 sites/tooth 
(disto-buccal, buccal, mesio-buccal, disto-lingual, lingual, mesio-lingual) using 
a periodontal probe (PCPUNC 15® Hu Friedy, USA) (Studies II, III, IV & V). 
 
Recession was assessed from the cemento-enamel junction (CEJ) to the gingival 
margin or from a restorative margin if the CEJ was not present (Studies I & V). 
 
Clinical attachment level (CAL) was calculated as PD plus recession (Studies 
I & V).  
Probing attachment level (PAL) was assessed by measuring the distance 
between fixed landmarks on individually fabricated stents and the bottom of the 
pocket (Studies III & IV). The reading of PAL was performed in connection 
with the PD measurement and without changing the location of the probe tip.  
Bleeding on probing (BoP) was assessed at 4 sites per tooth (mesial, buccal, 
distal, ligual) as present or absent, in conjunction with the PPD measurements 
(Ainamo & Bay 1975) (Studies I, III, IV & V). 
  
Microbiological sampling. A bacterial sample was obtained from each of the 
selected sites using 2 sterile, medium-sized paper points (Study I). 
Supragingival plaque and calculus were removed and the tooth surface was 
dried with sterile cotton pellets. The paper points were inserted into the pocket 
until definite resistance was met and were then kept in place for 30 seconds. The 
paper point samples were placed in an anaerobically prepared transport medium 
and processed the same day. 
 
Radiographic bone level (Rxbl). A set of full-mouth intraoral radiographs was 
obtained at the baseline examination  (Studies I, III, IV &V) and at the final 
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examination (Study V) using a standardized parallel technique (Eggen 1969). 
The location of the marginal alveolar bone in relation to the cemento-enamel 
junction (CEJ) was measured at the mesial and distal aspects of all non-molar 
teeth present. The radiographs were analyzed using a digitizing system 
connected to a specially developed computer program (Status XR, AEC, 
Göteborg, Sweden) that automatically calculated the linear distances that were 
identified (Studies III, IV & V). 
Registrations 
One examiner performed all the measurements in Studies I, II & V (Center A). 
There were 2 calibrated examiners in Studies IV & V (Center B) and 3 
calibrated examiners in Study III. 
 
Patient selection 
In Study I, the subjects were selected from patients referred to the Department 
of Periodontology, University of Gothenburg, for the treatment of moderate to 
severe periodontitis.  
In Study II, the subjects were volunteers with no signs of destructive 
periodontal disease, recruited at the Specialist Center, Department of 
Periodontology, Uddevalla, Sweden.  
In Studies III and IV, the patients were recruited from a larger group of patients 
who, in 1982-1984, were referred to the Department of Periodontology, 
Helsingborg, Sweden, for the treatment of advanced periodontal disease. 
In Study V, the subjects were selected from patients referred to the Specialist 
Center, Department of Periodontology in Uddevalla, Sweden (Center A) and to 
a private dental practice in Aurora, Colorado, USA (Center B).  
All the studies were performed in collaboration with the Department of 
Periodontology, Institute of Odontology, University of Gothenburg, Sweden. 
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Data analysis 
Student’s t-test was used to analyze difference over time between mean values 
(on subject level) for clinical and microbiological parameters in study I. 
Differences between the test and control groups as differences over time and 
analysis of variance were performed in study III, IV and V. In study V 
differences between the groups at patient entry were examined using Fisher’s 
exact tests. Nonparametric Wilcoxon statistics were used to validate findings of 
the parametric t-test and Levine’s test assessing homogeneity of variance. The 
Gail and Simon test was performed to determine whether there was any 
evidence of treatment by center interaction. In study II one factor ANOVA using 
the treatment where the factor was used to detect if significant differences 
between the products existed. 
For each of the variables mean values and standard deviation were calculated for 
the treatment group and subject level.  
 
Material and methods 
Study I 
Twelve subjects (5 males) aged 44 to 69 years with moderate to severe 
periodontal disease participated in the study. The subjects were otherwise 
healthy and had not received any periodontal therapy during the last 12 months 
or received antibiotics during a 3-month period preceding the study.  
Based on a full-mouth screening examination, including the assessment of 
plaque, (+/-) gingivitis (+/-) and probing depth on 4 surfaces per tooth (Nyman 
& Lindhe 1983), 6 to 8 sites per subject were selected which had a probing 
depth of ? 5 mm. Of these sites, at least one had a pocket with a suprabony 
location and an infrabony location and at least one site was located at a furcation 
defect of Degree II (Hamp et al. 1975).  
The total sample comprised 25 suprabony sites, 20 infrabony sites and 22 
furcation sites. 
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Figure 1. Baseline examination. Microbiological samples 
Professional plaque control 2-3 times /week 
Reexamination and microbiological samples at 30 weeks 
 
A full-mouth clinical examination was performed at baseline and after 30 
weeks, including examination of the selected sites where assessments of GI, PlI, 
PPD and PAL and bacterial samples were made for microbiological 
examinations. 
The total viable count (TVC) and the percentage of P. gingivalis were 
calculated. 
At the baseline examination, the patients were instructed and trained in good 
OH, followed by thorough supragingival scaling. During the subsequent 30 
weeks, the patients were recalled 2-3 times a week for PTC by a dental hygienist 
(Axelsson & Lindhe 1974) and the patients’ oral hygiene was checked and, if 
necessary, corrected. 
 
Study II 
One hundred and two subjects, aged 18-67 years, participated in the study. 
Subjects with no destructive periodontal disease but with gingival inflammation 
(GI) ? 1.0 and dental plaque ? 1.5 (QHI) were recruited.  
The subjects (i) should have a minimum of 24 teeth, (ii) should not have used 
antibiotics during the last 3 months prior to the study, (iii) should not have been 
on regular anti-inflammatory medication and (iv) should be non-smokers.  
The subjects were randomly assigned to a test group (magnolia) and a control 
group. The magnolia group comprised 51 subjects who were assigned to a 
 38 
dentifrice containing 0.3% magnolia extract and 0.243% sodium fluoride (1100 
ppm F). All the participants in the control group (51) used a corresponding 
fluoride dentifrice. The subjects were asked to continue to exercise their regular 
non-supervised, self-performed plaque control twice a day for the next 6 
months. Plaque (QHI) and gingivitis (GI) were registered at baseline and after 3 
and 6 months. 
 
 
 
Plaque (QHI)     X             X              X 
Ginigivitis (GI)   X             X                          X 
  
Adverse  Events             X              X 
  
 
Figure 2. Study II outline  
 
Study III 
Two hundred and twenty-three patients with advanced destructive periodontitis 
were recruited; they had (i) a minimum of 8 non-molar teeth, (ii) a probing 
pocket depth of ? 6 mm at ? 2 teeth in each quadrant and (iii) radiographic bone 
loss exceeding 40% in the same teeth.  
The study included one phase of basic therapy and 12 years of supportive 
periodontal therapy (SPT).  
Following the first baseline examination (Baseline I), the patients were stratified 
into 2 treatment groups (test and control). The groups were balanced in terms of 
age, gender, PPD and RxBL. The basic therapy included instruction in good 
self-performed OH measures and SRP. The OH instruction was repeated on an 
“individual need basis”, both during the basic treatment period and at recall 
visits during SPT. The SRP was carried out under local anesthesia and using an 
ultrasonic device (Odontoson M®, Copenhagen, Denmark). The supra- and 
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subgingival instrumentation was performed with the concomitant administration 
of 0.1% povidone-iodine (test group) or water (control group) as the cooling 
solution for the ultrasonic device.  
The non-surgical treatment required an average of 4-6 sessions, each lasting 50-
60 minutes, using 950 ml PVP iodine (test group) or water (control group).  
 
Following Baseline I, all subjects were examined after 3, 6 and 12 months. The 
12-month re-examination marked the end point of the outcome of basic therapy 
and became the starting point for the evaluation of the effect of maintenance 
therapy (Baseline II). Comprehensive re-examinations, including PI, BoP, PPD 
and PAL, were performed 3, 5 and 12 years after Baseline II, i. e. the patients 
were monitored for a period of 13 years.  
All the subjects were included in a maintenance program that included SPT 
every 3–4 months during the 12-year period. In conjunction with the recall 
visits, sites that exhibited BoP and PPD of ? 5 mm were subjected to 
subgingival therapy identical to the treatment provided during the basic therapy.  
Subjects who demonstrated an annual further loss of PAL of ? 2 mm at ? 4 sites 
between year 1 and 3 after Baseline II were removed from the study and referred 
for re-treatment.  
 
 
 
 
 
Figure 3. Study design. Baseline I (BLI): Initial examination. 0:Start of Basic therapy: 
Nonsurgical debridement: SRP + iodine (test). SRP alone (ctrl). 
Baseline II (BLII): Evaluation of basic therapy. Start of SPT 3-4 times/year.  
SRP + iodine (test). SRP alone (ctrl) 
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Drop outs  
During Baseline I – 13 years 8 subjects in the test group and 25 subjects in the 
control group withdrew from the trial for reasons unrelated to the study. These 
subjects were not included in the final data analysis. 
 
 
 
Study IV 
Thirty-five subjects (16 males) aged 24 to 60 years were included in the test 
group. Eighty gender-matched subjects were recruited for the control group (38 
males).  
The subjects should be > 20 years of age and have ? 16 teeth of which ? 2 teeth 
must be molars. The subjects should not have any systemic conditions which 
required antibiotic coverage for SRP, should not be pregnant, or allergic to 
tetracycline or have taken antibiotics during the previous 6 months. 
 
Clinical examinations including the assessment of plaque, BoP, PPD and PAL 
were performed at baseline and at re-examination after 1, 3, 5 and 13 years. 
Following the baseline examination, all patients were given instruction in 
effective self-performed plaque control measures.  
During the 3-week interval, all the participants received 4-6 sessions of SRP 
under local anesthesia. Each SRP session required about 60-90 minutes of 
treatment. The subjects in the test group started the antibiotic regimen, including 
250 mg of tetracycline hydrochloride (Tetracycline®, NM Pharma, Enköping, 
Sweden) 4 times a day for a period of 3 weeks. No drug therapy was given to 
the subjects in the control group. During the entire basic therapy phase, all the 
patients rinsed with a 0.2% CHX solution twice a day. 
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Following the termination of the basic therapy phase, all the patients were 
enrolled in a maintenance care program, including SPT 3-4 times per year. At 
each recall appointment, the quality of the self-performed plaque control 
measures was evaluated and, if necessary, corrected. Sites that bled on gentle 
probing and with a PPD of ? 5 mm were anesthetized and underwent renewed 
mechanical instrumentation. 
 
 
 
 
 
 
 
Figure 4. Baseline I ( BLI): Initial examination.0: Start of Basic therapy: Nonsurgical 
debridement:  (i) SRP +systemic Tetracycline (test). (ii) SRP alone (ctrl). 
Baseline II (BLII): Evaluation of basic therapy. Start of SPT, test & control, 3-4 times/year.  
 
Drop outs 
During the course of the 13 years of monitoring, a total of 26 subjects were lost. 
Seven subjects in the test group and 19 subjects in the control group withdrew 
from the trial for reasons unrelated to the study. Only subjects who remained in 
the study for the entire 13-year period were included in the analysis. 
 
Study V 
This study was a 6-month double-blind, parallel, prospective, 2-center study. 
Sixty patients aged 25 to 80 years who met the following inclusion criteria were 
included: a minimum of 12 non-molar teeth in 4 quadrants, ? 3 non-molar teeth 
per quadrant with 2 or more periodontal sites with bleeding on probing (BoP) 
and ? 1 site with a PPD of ? 6 mm.  
The baseline examination including PlI, BoP, PPD and PAL were assessed in all 
non-molar teeth. 
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The patients were randomized in a test and a control group. The patients in the 
test group received modified Widman flap surgery and minocycline 
microspheres (SMM) and the control group of 28 subjects (12 male) only 
received modified Widman flap surgery (SO).  
Following the baseline examination, all the patients were given instruction in 
effective self-performed plaque control and, if necessary, the plaque control was 
reinforced on each visit. Two quadrants in the test group was given local 
minocycline microspheres at baseline, immediately following each of 2 surgical 
therapies performed in weeks 2 and 3 and week 5. Each treatment site received a 
single dose of Arestin? (1mg of minocycline). The other surgery quadrants 
followed the same treatment regimen but without any antibiotic therapy. The 2 
remaining quadrants were treated with scaling and root planing, with or without 
Arestin?. 
 
 
Drop outs 
Thirty-one subjects were randomized to the SO group and 29 subjects to the 
SMM group and 1 subject in each group discontinued the study; 1 patient in the 
        S T U D Y OUTLINE 
 
Baseline Week 2  W e e k 3  W e e k 5  W e e k 13  Week 26 
_______________________________________________________________________________________ 
PD, CAL X  X  X  
BoP & PI 
Quadrant A SRP+M M  M M MM 
Quadrant B  SRP+M M  M M   MM    
Quadrant C  M M  MVF+MM MM       
      
Quadrant D  M M MVF+MM  M M 
 
 
PD: Pocket depth; CAL: Clinical Attachment level; BoP: Bleeding on Probing;  
SRP: Scaling and Rootplaning; MVF: Modified Widman Flap; MM: Minocycline Microspheres 
Surg: Surgery 
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SO group was removed because of a protocol violation and 1 patient in the 
SMM group due to non-serious reported joint pain.  
 
Results 
Study 1 
Clinical observations  
At the baseline examination, 82-100% of all sites harbored gross amounts of 
plaque (PlI ?2) and 100% bled on probing. At the 30-week examination, the 
percentage of sites with gross amounts of plaque was reduced to 14-19% and the 
percentage of sites with bleeding on probing was reduced to 20-32%. The 
reduction was statistically significant for all selected sites (p>0.001). 
Suprabony sites 
There were statistically significant reductions in mean probing depth (p<0.001) 
and the mean probing attachment level (p<0.05) between the examinations, as 
well as an increase in gingival recession (p<0.001). At baseline, 10 of the 25 
selected suprabony sites had a probing depth of 5 mm, 12 were 6 mm and 3 
were > 6 mm deep. At the 30-week examination, all but 2 of the sites showed a 
reduction in probing depth. As a result, 7 sites were ? 3 mm, 16 were 4 mm and 
2 were 6 mm deep. In other words, the professionally supervised plaque control 
regimen improved the clinical conditions at all suprabony sites, irrespective of 
their baseline depth. 
Infrabony sites   
There were no significant alterations in the mean probing depth (PPD) and the 
mean probing attachment level (PAL) during the 30-week interval. 
At 30 weeks, only 5 sites exhibited improved probing depth values; 1 site was 4 
mm, 6 sites were 5 mm, 7 sites were 6 mm and 6 sites were still ? 6 mm deep. 
No site displayed a PPD reduction of > 1 mm and at 3 sites a PPD increase of ? 
1 mm occurred. All infrabony sites showed the presence of plaque and bleeding 
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gingiva at baseline, while, at the 30-week re-examination, only 18% of the 
selected sites harbored visible amounts of plaque and only 20% were BoP 
positive. 
The probing depth change between baseline and 30 weeks was less conspicuous 
at sites with infrabony sites than at suprabony sites. In fact, there were no 
significant alterations in the mean probing depth (PPD) and the mean probing 
attachment level (PAL) during the 30-week interval. At baseline, 3 of 20 
infrabony sites were 5 mm deep, 13 were 6 mm and 4 sites had a PPD of > 6 
mm. At 30 weeks, only 5 sites exhibited improved probing depth values; 1 site 
was 4 mm, 6 sites were 5 mm, 7 sites were 6 mm and 6 sites were still 6 mm 
deep. No site displayed a PPD reduction of > 1 mm and at 3 sites a PPD increase 
of ? 1 mm occurred. 
Furcation sites 
Of 22 furcation sites involved in the study, 82% showed the presence of visible 
plaque and 100% bled on gentle probing at baseline. At the end of the 30-week 
interval of professional supragingival plaque control, the plaque and gingivitis 
scores had decreased to 19% and 32% respectively. 
There was a statistically significant reduction in the mean PPD (p<0.01) but not 
in the mean PAL between baseline and the 30-week examination. The amount of 
gingival recession was, however, significantly higher. At most furcation sites 
(21/22), the PPD at baseline varied between 5-6 mm. During the course of the 
therapy, 5 of the 9 sites in the 5 mm category and 5 of the 12 sites in the 6 mm 
category exhibited a PPD reduction of ? 1 mm. One site had a deeper probing 
depth value at 30 weeks than at baseline. 
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Microbiological observations 
Suprabony sites 
There was a statistically significant reduction in the mean TVC (x 105) counts 
between baseline and the 30-week examinations and the TVC counts were 
notably reduced for all suprabony pocket sites. Whereas at baseline the TVC 
counts were higher in deeper pockets than in more shallow pockets, no such 
trend could be seen at the end of the trial. The percentage of P. gingivalis in the 
subgingival samples was reduced in all PPD categories, but this reduction was 
not statistically significant. 
Infrabony sites 
The TVC (x 105) counts at sites with a PPD ? 5 mm at baseline were 
significantly reduced between the 2 examination intervals (p<0.01). This 
reduction occurred at initially deep as well as shallower sites and also at sites 
which maintained their probing depth. Moreover, the percentage of P. gingivalis 
was markedly reduced at all sites between baseline and the 30-week 
examination. 
Furcation sites 
The mean TVC was markedly reduced during the course of the trial. The 
percentage of P. gingivalis was significantly higher (p<0.05) at baseline than at 
the 30-week examination. Independent of the initial probing pocket depth, both 
the TVC count and the percentage of P. gingivalis were reduced between the 2 
examinations. 
 
Study II 
Ninety-four subjects completed the study. Eight subjects (5 from the test group) 
withdrew from the study for reasons not related to the ongoing trial.  
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Plaque 
There were no statistically significant differences between the groups at the 
baseline registration. The mean QHI score was 2.90 (SD±0.39) and 2.82 (0.32) 
in the magnolia group and the control group respectively.  
At the 3-month examination the mean QHI score was 2.50 (0.30) in the test 
group and 2.52 (0.28) in the control group, but the reduction was significantly 
higher (p<0.01) in the magnolia group. 
At the 6-month examination the mean QHI plaque score was 2.65 (0.40) and 
2.72 (0.33) in the magnolia group and the control group respectively. The mean 
QHI reduction was statistically significant in both the magnolia group and the 
control group (p<0.001 and p<0.05 respectively), but it was significantly larger 
in the magnolia group than in the control group (0.25±0.40 vs. 0.09±0.28; 
p<0.01).  
 
Percentage distribution of various QHI score categories  
At the baseline examination, an average of 3.6% (5.6) of the tooth surfaces in 
the magnolia group had a QHI score of 0/1, while the corresponding figure in 
the control group was 4.4% (4.8). The percentage of tooth surfaces with gross 
amounts of plaque (QHI 3/4/5) was 70.0% (19.7) and 65.4% (17.1) in the 
magnolia group and the control group respectively. 
At the 3-month examination the percentage of tooth surfaces with a QHI score of 
0/1 had increased to 12.6% (12.6) in the magnolia group and 11.2 % (10.9) in 
the control group. The percentage of surfaces with large amounts of plaque 
(QHI 3/4/5) had decreased to 52.1% (22.0) in the magnolia group and 56.2% 
(19.3) in the control group. The change was statistically significant within the 
two treatment groups (p<0.001), but the participants receiving the magnolia 
regimen obtained a significantly higher reduction in QHI scores 3/4/5 than the 
control group (17.8% vs. 9.2%) (p<0.01).  
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At the 6-month examination the mean percentage plaque score of 0/1 was 7.2% 
(12.6) in the magnolia group and 5.3% (7.2%) in the control group. The 
corresponding percentage of surfaces with scores of 3/4/5 was 59.8% (19.3) and 
62.1% (18.1) respectively.  
The change in the various QHI score categories between baseline and 6 months 
was statistically significant in the magnolia group (p<0.001) but not in the 
control group. The participants receiving the magnolia regimen obtained a 
significantly higher reduction in QHI scores of 3/4/5 than the control group 
(10.2% vs. 3.2 %) ( p<0.05). 
 
Gingivitis 
At baseline the mean GI score was 1.34 (0.16) and 1.30 (0.12) in the magnolia 
group and the control group respectively.  
At the 3-month examination the mean GI score was 1.07 (0.18) in the magnolia 
group versus 1.16 (0.14) in the control group. The reduction was statistically 
significant in both treatment groups (p<0.001), but it was significantly higher in 
the magnolia group than in the control group; 0.27 (0.13) vs. 0.15 (0.14); 
p<0.001.   
At the 6-month examination the mean GI score was 1.08 (0.14) in the magnolia 
group and 1.19 (0.12) in the control group. The mean GI reduction was 
statistically significant in both the magnolia group and the control group 
(p<0.001), but it was significantly higher in the magnolia group (0.26 ± 0.11) 
than in the control group 0.11 (0.12) (p<0.001). 
 
Percentage distribution of various GI score categories  
At the baseline examination the mean percentage of healthy gingival sites was 
2.9% (3.6%) in the magnolia group and 2.8% (3.2%) in the control group. The 
percentage of sites with a GI score of 2/3 was 36.5% (14.0%) and 32.8% 
(11.3%) in the magnolia group and the control group respectively. 
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At the 3-month examination the mean percentage of healthy gingival sites (GI 0) 
had increased to 10.7% (9.3%) in the magnolia group and 6.9%  (6.8%) in the 
control group. The percentage of sites with a GI score of 2/3 had decreased to 
17.4% (11.1%) in the magnolia group and 22.3% (10.7%) in the control group. 
The changes between baseline and the 3-month examination were statistically 
significant in both treatment groups (p<0.001).  
At the 6-month examination the percentage of sites (GI 0) was 7.2% (6.6%) in 
the magnolia group and 3.7%  (3.8%) in the control group. The percentage of 
sites with a GI score of 2/3 was 14.8% (9.1%) in the magnolia group and 22.9% 
(9.6%) in the control group. The change in the various GI score categories was 
statistically significant in the two treatment groups (p<0.001), apart from the GI 
score 0 category in the control group. The subjects in the magnolia group 
displayed a significantly larger increase in the percentage of healthy gingival 
sites (3.5% vs. 0.9%; p<0.01) and a significantly higher reduction in inflamed 
gingival sites compared with the control group (21.7% vs. 9.8 %; p<0.001).  
Number of sites with various GI scores 
The number of sites with GI scores of 0, 1 and 2 in the magnolia group and the 
control group at baseline and 6 months were calculated. The number of healthy 
sites (GI = 0) increased from 207 sites to 517 sites (150%) in the magnolia 
group. The corresponding increase in the control group was 213 sites to 278 
sites (31%). 
The number of gingival units showing overt signs of gingival inflammation in 
the magnolia group (GI score 2) was reduced from 2582 sites to 1045 sites 
(60%), while the corresponding reduction in the control group was from 2483 
sites to 1734 sites (30%). 
At the 3-month and 6-month examinations, significantly less clinical signs of 
gingivitis were observed in the magnolia group than in the control group at sites 
adjacent to tooth surfaces harboring the same amount of plaque. 
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Study III 
Drop outs and excluded subjects 
During the basic therapy phase 9 subjects, 1 in the test group and 8 in the control 
group, withdrew from the trial for reasons unrelated to the study. Seven subjects 
in the test group and 17 subjects in the control group withdrew from the study 
during the maintenance phase. In addition, during the first 2 years after active 
treatment, 31 subjects from the control group and 9 from the test group were 
excluded due to further disease progression (? 2 mm PAL loss at ? 4 teeth per 
year). The percentage of “ loser subjects” was higher in the control group 
(25.2%) than in the test group (13.4%). No subjects with additional CAL loss ? 
2 mm were identified between years 3 and 13. 
As a result, the data analyses were based on 58 subjects in the test group and 92 
subjects in the control group, who remained in the study during the entire 13-
year period of monitoring.  
Baseline I    
The mean age of the subjects was 44 years in both groups and 51% and 57% 
were males in the test and control groups respectively. The mean number of 
non-molar teeth was 18.7 in the test group and 18.3 in the control group. Some 
30% of all tooth surfaces exhibited the presence of plaque and 66-69% of all 
gingival units were BoP positive.  
The mean PPD was 3.9 mm (0.9 mm) in the test group and 3.7 mm (0.9 mm) in 
the control group. In both groups, about 50-54% of all sites had shallow pockets 
(?3 mm), 28-29% medium-deep pockets (4-5 mm) and 18-21% had deep 
pockets (?6 mm). The mean RxBL was 6.5 mm (1.2 mm) in the test group and 
6.7 mm (1.3 mm) in the control group. No statistically significant differences in 
the clinical or radiographic variables were found between the two groups at 
Baseline I. 
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The effect of basic therapy  (Baseline I – 12 months) 
During the basic therapy phase, 0.5 (2.0) teeth in the test group and 0.3 (2.0) in 
the control group were extracted. In both groups, a significant improvement was 
observed in oral hygiene conditions. The plaque score was reduced from 30% at 
Baseline I to about 4-8% at 3 months and the percentage of BoP-positive sites 
was reduced from about 70% to 20-25% and remained at these reduced levels in 
both study groups at the 6- and 12-month re-examinations.  
The mean PPD value decreased in the test group from 3.9 mm at Baseline I to 
2.8 mm (mean reduction 1.1 mm) at 3 months. The corresponding decrease in 
the control group was 0.8 mm (from 3.7 mm to 2.9 mm). The difference in PPD 
reduction between the test group and the control group was statistically 
significant (p<0.05). The reduced mean PPD value in both groups was 
maintained at the 6- and 12-month re-examinations.  
Both treatment groups showed a gain in PAL at 3 months; test group 0.5 mm  
(0.5 mm), control group 0.3 mm (0.5 mm) (p<0.001). In the test group, the PAL 
gain was maintained at the 6- and 12-month examinations, while the control 
group displayed a tendency to lose the initial attachment gain. As a result, at 12 
months, the subjects in the test group displayed an average PAL gain from 
baseline of 0.4 mm, while the corresponding gain in the control group was 0.1 
mm (p< 0.001). 
The data from the 3-month re-examination revealed that the PAL gain in the test 
group in initially medium-deep pockets (4–5 mm) was 0.7 mm, while it was (?6 
mm) 1.5 mm in deep pockets. The corresponding PAL gains in the control group 
were 0.4 mm and 1.1 mm respectively. The gain in both site categories was 
significantly higher in the test group than in the control group (p<0.01).  
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Baseline II findings  
At the 12-month examination, there was an average of 18 non-molar teeth in the 
2 groups, between 6-8% of the tooth surfaces harbored plaque and in 22-25%  of 
all sites the gingival units were BoP positive. The overall mean PPD was 
significantly (p<0.01) lower in the test group than in the control group (2.7 mm 
vs. 2.9 mm). The percentages of shallow (? 3mm), medium-deep (4-5 mm) and 
deep (?6 mm) pockets in the test group were 79%, 19% and 2% respectively. 
The corresponding percentages in the control group were 74%, 21% and 5%. 
 
Re-examinations after 3, 5 and 13 years 
During the 12 years of SPT, an average of 1.3 teeth were lost in the test group 
and 2.4 teeth in the control group (p < 0.05). During the maintenance period, the 
mean plaque scores varied between 3% and 17% in the 2 study groups. The 
percentage of BoP-positive sites varied during the same period between 17-33%. 
The mean PPD increased in both groups between Baseline II and the 13-year 
examination. The mean annual PPD increase was 0.02 mm on average in the test 
group and 0.03 mm on average in the control group. The mean PPD at the final 
re-examination was 2.9 mm in the test group and 3.3 mm in the control group (p 
< 0.01).  
The frequency of shallow pockets (? 3 mm) remained high in both groups in the 
interval between Baseline II and 13 years (67-76%), while the frequency of deep 
pockets (? 6 mm) in the control group tended to increase over time; from 5% at 
Baseline II to 8% at the final examination.  
In both groups, there was some loss of PAL during the 12 years of SPT. The 
annual PAL loss amounted to 0.06 mm in the test group and 0.08 mm in the 
control group. During the entire 13-year period of observation (Baseline I – 13 
years), the total mean PAL loss in the test group was 0.28 mm. The 
corresponding loss in the control group was 0.87 mm (p<0.001). 
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Study IV 
Baseline examination 
The patients in the 2 study groups were 41.2 and 42.1 years of age on average. 
In the test group, 60% were smokers, while the corresponding figure in the 
control group was 56%.   
The patients in both groups had a mean of 25 teeth (3rd molars excluded), of 
which 18 were non-molars.  
In the test group, 33% of all tooth surfaces harbored plaque and the 
corresponding figure in the control group was 28%, while 71% (test) and 67% 
(control) of the gingival units bled on gentle probing (BoP). The individual 
mean PPD values were 4.2 mm for the test group and 3.9 mm for the control 
group (p<0.05), while the mean amount of bone loss assessed on radiographs 
(RxBL) was 6.5 mm in the test group and 6.6 mm in the control group. The 
frequency of shallow pockets (? 3 mm) was 43% in the test group and 49% in 
the control group, while deep pockets (? 7 mm) occurred at a frequency of 15% 
and 12% in the 2 groups. None of the parameters assessed at baseline differed 
significantly between the 2 groups, apart from the mean PPD (p<0.05). 
 
Re-examinations  
1 year 
During the first year of non-surgical basic therapy, 0.5 teeth were extracted in 
both the test group and the control group. The re-examination at the 1-year 
follow-up revealed that, in both treatment groups, there was a statistically 
significant reduction in (i) the percentage of plaque-harboring surfaces (-26% 
and -23%) and BoP+ sites (-49% and -38%), (ii) mean PPD values (-1.0 mm and 
-0.7 mm) and (iii) the percentage of deep pockets (-11% and -8%). In addition, 
in both groups, there was a significant clinical attachment level gain in both the 
test group (0.47 mm) and the control group (0.16 mm). The PAL gain in the test 
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group and the control group was significantly larger than in the control group 
(p<0.001).  
In both groups, there was some PAL loss at sites with initially shallow pockets, 
while there was a gain at sites with an initial PPD of ? 4 mm. Furthermore, the 
PAL gain was more pronounced at sites which had a PPD of ? 7 mm at baseline 
than at sites in the 4-6 mm PPD category. The PAL gain in the test group was 
significantly (p> 0.05) greater than in the controls. In addition, for both medium-
deep and deep pockets, the PAL loss at shallow pocket sites was significantly 
smaller in the test group than in the control group (-0.10 mm vs.-0.35 mm) (p< 
0.05). 
3, 5 and 13 years 
The findings from the re-examinations after 3, 5 and 13 years showed that, 
during the course of SPT, a mean of 1.7 (2.1) teeth were lost in the test group 
and 2.7 (3.7) teeth in the controls (p< 0.01). The percentage of BoP-positive 
sites remained at a low level throughout the 12-year period. The mean individual 
PPD value, which was reduced between baseline and year 1, was still reduced at 
the 5-year re-examination. Between 5 and 13 years, however, there was a 
significant PPD increase in both groups (p< 0.05). The percentage of sites with 
deep pockets therefore increased in both groups from an average of 3-4% to 8% 
(test group) and 7% (control group).  
Moreover, the initial (baseline to year 1) gain in the mean probing attachment 
level gradually diminished. In the control group, the attachment gain was lost at 
the 3-year re-examination. The 0.47 mm PAL gain that was initially obtained in 
the test group was lost after 5 years of SPT.  
The annual PAL loss that occurred in both groups after the first year was (i) 
small and varied between 0.07 and 0.11 mm and (ii) was of similar magnitude in 
the 2 subject groups. 
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Study V 
Baseline examination 
In the SO group, 25.5% of the pockets were ? 5 mm, while the corresponding 
figure in the SMM group was 26.3%. The mean PPD of all 5 mm pockets was 
5.8 mm and 5.7 mm in the SO and the SMM group respectively. The CAL was 
6.6 mm in the SO group and 6.7 mm in the SMM group. None of the parameters 
assessed at baseline differed significantly between the 2 groups. 
Re-examinations  
During the 6 months, 12 patients lost 14 teeth, but only 3 of these teeth were 
non-molar teeth in the surgery quadrants.  
The re-examination at the 3- and 6-month follow-up revealed that, in both 
treatment groups, there was a statistically significant reduction in  
(i) BoP+ sites, 62% at 3 months and 56% at 6 months in the SO group 
and 64% at 3 months and 64% at 6 months in the SMM group, with no 
statistically significant difference and  
(ii) mean PPD reduction, 2.29 (0.09) mm at 3 months and 2.18 (0.10) mm 
at 6 months in the SO group and 2.48 (0.10) and 2.5 (0.10) mm 
respectively for the SMM group. The difference in the mean PPD 
between the two groups at the 6-month examination was statistically 
significant (p< 0.05). 
(iii) In smokers, a reduction in BoP+ sites of 64% (5) at 3 months and 54% 
(4) at 6 months was observed in the SO group and 70% (5) and 66% 
(4) at 3 months and 6 months in the SMM group, with no statistically 
significant difference between the groups. 
(iv) Smokers displayed a mean PPD reduction of 2.17 (0.11) mm and 2.05 
(0.09) mm in the SO group at 3 and 6 months respectively. For the 
SMM group, the corresponding PPD reduction was 2.40 (0.11) and 
2.30 (0.09) mm respectively. The difference between the two groups at 
the 6-month examination was statistically significant (p< 0.05). 
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(v) Calculations of the number and percentage of sites showing a PPD 
reduction of ? 1, ? 2 and ? 3 mm between baseline and 3 months by 
smoking status in the SO group and SMM group respectively revealed 
that non-smokers in the SMM group had significantly fewer 
periodontal sites of ? 2. This difference also remained at 6 months. For 
smokers in the SO and SMM groups, this difference was even more 
pronounced at sites of both ? 2 and ? 3 mm at both 3 and 6 months for 
patients in the SMM group.  
(vi) No differences in CAL were observed in this study and this is in 
agreement with the study by Williams et al. (2001). 
 
The differences between the smokers in this study showed a significant 
difference between the treatment groups in terms of PD change in favor of the 
patients in the SMM group. Despite this, the non-smokers experienced more 
pocket depth reduction in both treatment groups. 
 
 
Discussion and Conclusions 
Study I 
The suprabony sites showed a decrease in the probing depth, which was 
explained partly by the recession of the gingival margin during the 30-week 
interval and partly by an improved probing attachment level. A probing 
attachment gain of ? 1 mm occurred at 13 sites, while a gain of > 1 mm 
occurred at only 4 sites. At the infrabony sites, the probing depth reduction was 
due to the recession of the gingival margin (p<0.05) and not to any obvious 
improvement in PAL. Between baseline and 30 weeks, a PAL gain of 1 mm was 
observed at 5 sites, while no sites with an attachment gain of > 1 mm could be 
found. Probing attachment loss (? 1 mm) was found at 4 sites. 
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At the furcation sites, the main reason for the reduced PPD was gingival 
recession, while a few sites exhibited attachment gain. Eleven sites disclosed a 
gingival recession of ? 1 mm and only 5 sites showed a PAL gain (? 1 mm). 
Attachment loss amounting to ? 1 mm occurred at 2 sites with an attachment 
level at baseline of 7 mm. 
  
The probing depth measurements in the present study revealed that the overall 
number of sites with ? 3 and 4 mm deep pockets increased, while the number of 
5 mm deep pockets decreased. This observation is in agreement with data 
presented by Dahlén et al. (1992) and Sato et al. (1993), who reported that 
subjects who were enrolled in a carefully monitored but self-performed plaque 
control program over periods of 2-3 years exhibited an increase in sites with a 
PPD of ? 3 mm and a decrease in the number of pockets in the 4-5 mm 
categories. In the study referred to, it was also stated that improved oral hygiene 
failed to alter the number of sites with ? 6 mm deep pockets. However, in the 
present study, in which professional, supragingival tooth cleaning (3 times 
/week) was practiced, sites with initially deep suprabony pockets also exhibited 
a pronounced PPD reduction during the course of the experiment; from an 
average of 5.9 mm at baseline to 3.8 mm after 30 weeks of therapy. This result 
confirms findings by McNabb et al. (1992) and emphasizes the fact that 
prolonged periods of professionally administered supragingival tooth cleaning 
may result in a significant recession in the gingival margin, even at sites with 
deep suprabony pockets. It should be observed, however, that, in the current 
study, the improvements in the probing measurements and the amount of soft 
tissue recession were less pronounced at infrabony and furcation sites. 
 
Microbiological observations 
One important observation made in the current trial was that the supragingival 
plaque control regimen had a marked effect on the subgingival microbiota. At 
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sites with suprabony and intrabony pockets, as well as at furcation sites, the 
treatment therefore caused a reduction in the total number of microorganisms 
that could have been harvested, as well as the percentage of P. gingivalis. This 
observation is in agreement with findings previously reported by Smulow et al. 
(1983), McNabb et al. (1992), Dahlén et al. (1992), among others, and confirms 
that the subgingival microbiota is at least partly dependent on the supragingival 
environment. On the other hand, it may be argued that the probing depth 
reduction, which occurs during periods of enhanced plaque control, due to 
continuous gingival recession, may change the subgingival environment and 
thereby explain the ensuing change in the microbiota. This would then imply 
that oral hygiene regimens per se only have an indirect impact on the 
subgingival flora. In the present subject sample, however, it was found that, 
even at sites where no pocket depth reduction occurred, the TVC and the 
percentage of P. gingivalis were substantially reduced. This observation (i) 
tends to validate the suggestion by McNabb et al. (1992) “that the niche 
occupied by P. gingivalis in moderately deep pockets may be rather tenuous” 
and (ii) indicates that this hypothesis is also valid for deep pockets with different 
locations and anatomy.  
Haffajee et al. (2001) reported that, as a result of self-performed plaque control 
measures, the composition of the microbiota associated with periodontitis in the 
pocket was altered and the percentage of periodontopathic bacteria was lowered. 
These results are in agreement with results observed by Del Peloso Ribeiro et al. 
(2005), who found a significant reduction in the microbiota associated with 
periodontitis compared with baseline values in the subgingival environment 
detected by measuring the level of trypsin-like enzymes (BAPNA test) 
possessed by microorganisms such as T. forsythensis, Treponema denticola and 
P. gingivalis after 21 days of a self-performed plaque control program. 
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The finding that improved supragingival plaque control may affect the 
subgingival environment and its microflora appears to disagree with results 
previously reported by Listgarten et al. (1998), Kho et al. (1992), Beltrami et al. 
(1986) and Loos et al. (1998), for example. In this context, differences in the 
experimental design must be considered. While, in the current trial, the 
participants were exposed to professionally administered tooth cleaning and 
concomitant oral hygiene instruction several times a week over a 30-week 
period, the oral hygiene improvements in the studies referred to were mainly 
dependent on patient compliance (self-performed plaque control). As a result, 
differences in the quality of the supragingival infection control and differences 
in bone topography may explain why different conclusions were reached with 
respect to the effect of supragingival plaque control on the subgingival biofilm. 
It was also observed that, at both categories of sites – suprabony and infrabony, 
there was a marked reduction in the subgingival microbiota. Both the TVC and 
the number of the marker species (P. gingivalis) were markedly reduced at both 
types of site between the baseline examination and the assessments made at the 
end of the clinical trial. 
There are therefore reasons to suggest that the subgingival microbiota is 
markedly influenced by the biofilm present in the supragingival environment 
and the associated inflammation in the overt gingiva. In this respect, it must be 
understood that, at sites with deep infrabony defects, supragingival plaque 
control may not change the subgingival biofilm sufficiently to prevent the 
progression of destructive periodontitis (Westfelt et al. 1998). 
 
Conclusions  
The findings indicate that professionally administered and frequently repeated 
supragingival tooth cleaning, combined with careful self-performed plaque 
control, had a marked effect on the subgingival microbiota of moderate to deep 
periodontal pockets. At sites with suprabony and infrabony pockets, as well as at 
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furcation sites, meticulous, prolonged supragingival plaque removal reduced the 
total number of microorganisms that could be harvested, as well as the 
percentage of sites with P. gingivalis. 
Supragingival plaque control – managed by professionals and self-performed 
efforts maintained for several months – resulted in the resolution of gingivitis 
and a reduction in the probing depth (PPD) at tooth sites with suprabony lesions 
and at furcation lesions. No corresponding PPD reduction occured at sites with 
infrabony lesions at which the hard tissue wall of the defect obviously prevented 
a substantial soft tissue recession.  
 
Study II 
The finding that 6 months of non-supervised tooth brushing with a dentifrice 
containing 0.3% magnolia extract had a more pronounced effect on dental 
plaque and gingivitis than a corresponding control dentifrice is in agreement 
with observations reported from other studies in which antiseptic and anti-
inflammatory dentifrices and mouth rinses were included as adjunctives to 
selfperformed oral hygiene (Lindhe et al. 1993, Rosling et al. 1997, Charles et 
al.  2001, 2004). Furthermore, in the patients who used the magnolia dentifrice, 
less gingival inflammation was observed at sites harboring similar amounts of 
plaque compared with subjects using an ordinary fluoride dentifrice. Schätzle 
and coworkers (2004) reported that teeth that were observed with healthy 
gingival conditions at every examination interval during a 26-year period had a 
99.5% chance to be maintained  compared with 65.4% for teeth that were 
always diagnosed with gingival bleeding. Methods to enhance plaque control 
and reduce the inflammation may therefore increase tooth survival. The herb 
extract magnolia has been shown to retard plaque and gingival inflammation in 
a test group of individuals compared with a control group, without producing 
any adverse events. However, in the present study, the subjects were not 
instructed in optimal plaque control and the degree to which an optimized 
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mechanical plaque regimen may have influenced the results without any 
antiseptic or anti-inflammatory agents was not investigated in the present study.  
Compared with other antiseptic and anti-inflammatory agents incorporated in 
dentifrices and mouth rinses, 0.3% magnolia extract exerts comparable effects 
on gingivitis to those obtained by e.g. by triclosan and Listerine®. 
Conclusions 
It was observed that six months of unsupervised tooth brushing with a dentifrice 
containing 0.3% magnolia extract resulted in a significantly larger reduction in 
plaque and gingivitis compared with a control dentifrice and less gingival 
inflammation at sites with similar amounts of plaque. 
  
Study III 
It was observed that PVP iodine, applied topically during non-surgical 
periodontal therapy, influenced treatment outcome. During the first year of 
observation, there was both a PPD reduction and a probing attachment level 
(PAL) gain in the test group that was more pronounced than in the control group 
However, the effect of PVP iodine during the maintenance phase (1-13 years) 
was less marked than during the basic therapy phase. It was also observed that 
the effect of PVP iodine was more pronounced in initially deep pockets than in 
shallow pockets. It is therefore suggested that the use of PVP iodine in non-
surgical treatment, as well as during supportive periodontal therapy in patients 
with advanced periodontal disease, may lead to an enhanced, more long-lasting 
outcome, i.e. reduced signs of gingivitis, more shallow pockets and more PAL 
gain. 
These findings are in agreement with data previously presented from clinical 
studies by Rosling et al. (1986), Christersson et al. (1988) and Forabosco et al. 
(1996), in which 0.5% PVP iodine was used in conjunction with non-surgical, 
ultrasonic scaling. Hoang et al. (2003) presented microbiological results 
showing that subgingival flushing with 10% PVP iodine for 5 minutes as an 
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adjunct to SRP resulted in a reduction in the total number of pathogens of at 
least 95% in 43.8% of the study sites, whereas, in three other treatment groups, a 
corresponding reduction from 6.3% to 12.5% of study sites was observed.  
However, in the current investigation, a lower concentration of the agent was 
used. The decision to use a 0.1% solution of PVP iodine in the current study was 
based on findings reported by Caufield et al. (1987). They used the membrane 
transfer technique to demonstrate that both 0.1% and 0.5% solutions of iodine 
had a bactericidal effect on Aggregatibacter actinomycetemcomitans, 
Porhyromonas gingivalis and Prevotella intermedia within a 5-minute period of 
exposure.  
However, the beneficial effect of PVP iodine in conjunction with ultrasonic 
scaling has not been verified in studies by Grossi et al. (1997) or Leonardt et al. 
(2006, 2007). Grossi et al. (1997) did not find any adjunctive effect from either 
CHX, or PVP iodine when used in the cooling system during ultrasonic 
debridement. In the study by Grossi et al. (1997) the patients also received 
systemic administration of doxycycline during the active treatment phase. The 
study did not include any treatment group subjected to ultrasonic scaling 
combined with PVP iodine alone. In the study by Leonhardt et al. (2006, 2007), 
the clinical outcome of ultrasonic scaling combined with 0.5% PVP iodine was 
examined in 20 patients. A split-mouth design, including ? 1 single-rooted 
tooth/quadrant with ? 1 site with an initial PPD of ? 6 mm, was used. All the 
defects had a suprabony location. The 6-month evaluation revealed no 
differences in the reduction of PPD, i.e. at the sites subjected to ultrasonic 
scaling with either PVP iodine or saline used in the cooling system. The 
quadrants subjected to ultrasonic scaling with or without 0.5% PVP iodine 
solution showed a significant reduction in both PPD and BoP, but the two 
treatment modalities were not significantly different. The results of the 
microbiological examination (Leonhardt et al. 2007) showed a reduction in 
periodontal pathogens by ultrasonic scaling but with no adjunctive effect from 
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PVP iodine. A distinction that could have had an impact on the result is the 
different study design in the two trials. A split-mouth design can minimize the 
difference between test and control sites, as the antiseptic is distributed into the 
oral cavity and affects the microbes not only in the saliva but also in niches in 
the tongue and mucosa (Quirynen et al. 2000). Furthermore, the untreated 
control sites may serve as reservoirs for translation and re-population of 
pathogentic microorganisms to the test sites which also may have an inpact on 
the results (Hoang et al. 2003).  
The effect of PVP iodine during the maintenance phase (1-13 years) was less 
marked than during the basic therapy phase. However, the data indicated that the 
adjunctive use of PVP iodine for the supportive periodontal therapy at each 3- to 
4-month recall visit in patients with advanced periodontal disease resulted in 
more shallow pockets and more probing attachment gain than was seen in the 
patients in the control group. 
 
Conclusions 
The findings from the present study demonstrated that the topical application of 
0.1% povidone (PVP)-iodine, used as a cooling agent in conjunction with 
ultrasonic, subgingival root debridement, established conditions that improved 
the outcome of non-surgical therapy. At the first re-examinations after active 
therapy (the 3-, 6- and 12-month examinations), the subjects in the test group 
exhibited significantly lower mean probing pocket depth values and had 
significantly more gain in probing attachment than the subjects in the control 
group. It was further observed that the effect of PVP iodine was more 
pronounced in initially deep pockets than in shallow pockets. In addition, the 
number of “loser subjects” (losers), i.e. subjects exhibiting further disease 
progression during the first phase of SPT, was much smaller in the test group 
than in the control group. Whether measured by (i) the percentage of losers, (ii) 
the initial gain in attachment or (iii) long-term PAL monitoring, the test group 
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exhibited approximately half the rate of disease progression compared with the 
control group.  
 
 
Study IV  
The finding that adjunctive treatment with systemic tetracycline may improve 
non-surgical periodontal therapy is in agreement with findings reported by 
Listgarten et al. (1978), Slots et al. (1979), Lindhe et al. (1983), Lundström et al. 
(1984) and Palmer et al. (1996), for example. However, in the present trial, it 
was noted that, in shallow pockets, the PAL loss was significantly smaller in the 
test group than in the control group and the PAL gain at deeper sites was 
significantly greater in the test group than in the control group. These 
observations appear to indicate that tetracycline, in one way or another, may 
have protected from attachment loss in shallow pockets and promoted 
attachment gain at deeper sites. A hypothesis of this kind is supported by the 
findings of Vernillo et al. (1994), who demonstrated that tetracyclines not only 
have antibacterial properties but may also inhibit the extracellular activity of 
collagenase released from mammalian cells. This metalloproteinase is of 
importance in the breakdown of collagen in inflammatory lesions and is also 
inhibited in later phases of proper wound healing. In addition, tetracyclines are 
potent inhibitors of osteoclast function. There are therefore reasons to suggest 
that tissue damage caused by subgingival instrumentation during the basic 
treatment phase at both shallow and deep sites may have been diminished in the 
patients treated with tetracycline. Furthermore, it was observed that tetracycline, 
administered systemically during the active phase of therapy, had a positive 
impact on treatment outcome in terms of PAL gain. 
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Conclusion 
It was observed that tetracycline, administered systemically during the active 
phase of therapy, had a positive impact on treatment outcome in terms of PAL 
gain. One year after active therapy, the probing attachment level in the test 
group was almost 3 times higher than in the control group.  Re-examinations 
after 3, 5 and 13 years of SPT disclosed that this short-term benefit was not 
maintained in the longer perspective.  
It was noted that the small amount of annual loss of attachment that occurred 
between years 1 and 13 did not differ between the 2 groups (0.07 mm and 0.11 
mm). 
 
Study V 
It was observed that minocycline microspheres applied topically during surgical 
periodontal therapy improved the treatment outcome. During these 6 months of 
observation, there was a PPD reduction in the test group that was more 
pronounced than in the control group, where the treatment included surgical 
periodontal therapy without any adjunctive antibiotic. Subgingival applications 
of minocycline microspheres produced a significantly larger reduction (0.3 mm) 
in mean probing depth in combination with periodontal surgery in adults with 
moderate to severe, chronic periodontitis than surgery alone in both smokers and 
non-smokers. These results are not in agreement with Palmer et al. (1996) or 
Needlemann and coworkers (2000), who did not find any additional effect from 
adjunctive antibiotic therapy during periodontal surgery. Palmer et al. (1996) 
treated 38 patients with aggressive periodontitis (i) with SRP and 250 mg x 4 of 
systemic antibiotics for 14 days and concluded that this was a useful adjunct to 
non-surgical treatment. At re-examination after 3 months, (ii) periodontal 
surgical treatment with a modified Widman flap and a renewed prescription of 
250 mg x 4 of systemic antibiotics for 14 days in teeth with a PPD of ? 5 and 
BoP were given. The authors concluded after 12 months that “no further 
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advantage was obtained by the antibiotic in the surgical phase, although this 
may also be a result of the smaller number of subjects and fewer sites treated in 
the surgical phase”. Needlemann et al. (2000) studied the additional effect of 
25% metronidazol gel as an adjunct to Modified Widman Flap (MWF) surgery. 
Forty-three patients with moderate to advanced periodontal disease were 
followed in a randomized, single-blind, parallel-armed study for 12 months. At 
the 12-month re-examination, no adjunctive effect from the local antibiotitic was 
observed, with a PD reduction of 3.7 and 3.6 mm in the test and control group 
respectively.  
Smoking as a lifestyle factor in periodontitis-susceptible individuals has been 
shown significantly to increase attachment and tooth loss (Bergström et al. 1989, 
Axelsson et al. 1998, Paulander et al. 2004).  Substances from tobacco produced 
during smoking have been shown to enhance the metalloproteinase action and 
have a negative impact on the collagen in periodontal connective tissue 
(Goodson 1989). Bergström et al. (1989) found 56% of smokers in a group of 
155 patients suffering from severe periodontitis. From a random sample of 
subjects of equal numbers (control group) but with no knowledge of their 
periodontal status, the percentage of smokers was calculated. In this control 
group, 34% of the subjects were smokers. Furthermore, Paulander and 
coworkers (2004) investigated the age group of 50 years in a cross-sectional 
study. They found significantly more attachment and tooth loss in smokers than 
in non-smokers. Vernillo and coworkers (1994) reported that tetracycline may 
reduce collagenase activity in the inflammatory connective tissue and also 
inhibit osteoclast activity. These findings may in part explain why smokers who 
have increased attachment loss and collagenase and osteoclast activity compared 
with non smokers, may respond with less attachment loss and reduced pocket 
depths when treated with minocycline. 
 
 
 66 
 
 
Conclusion  
After 6 months, the subgingival application of minocycline microspheres 
produced a significantly greater reduction (0.3 mm) in mean probing depth in 
combination with periodontal surgery in adults with moderate to severe, chronic 
periodontitis than surgery alone, in both smokers and non-smokers. 
 
 
 
 
Future considerations 
Six months use of a dentifrice containing 0.3 % magnolia extract in patients 
with gingivitis resulted in less gingival inflammation (about 10%) than in 
patients brushing with a dentifrice without the magnolia extract. 
In patients with severe chronic periodontitis no difference in the percentage of 
bleeding sites was observed after treatment with ultrasonic SRP with or without 
0.1% Povidone iodine used as a cooling agent. However, both treatment 
regimens reduced inflammation in the periodontal tissues more than 40 %. 
Furthermore, SRP with or without adjunctive treatment with systemic 
tetracycline reduced the inflammation with an additional 10% compared to only 
SRP (49% vs 38%). Finally, in patients who were treated with surgery and 
topical application of minocycline around 60% less bleeding on probing was 
observed.  
Thus, there was a clinical albeit moderate effect on the level of gingival 
inflammation in subjects who brushed with a dentifrice containing magnolia 
extract. Also, the additional effect of tetracyclines, either administered 
systemically or topically, or iodine in adjunction to SRP and/or surgery had a 
limited effect on gingival bleeding.  
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Figure 6. Percentage of sites with bleeding on probing (BoP) 
 
The use of antiseptics/antibiotics as an adjunct to mechanical treatment during 
the active phase of periodontal therapy resulted in an additional mean pocket 
reduction of 0.3-0.4 mm. Furthermore, despite an increasing pocket depth which 
developed during the maintenance phase the differences observed between the 
test and control groups after active treatment was still maintained. Actually, 
during the PVP iodine regime the mean pocket depth reduction obtained after 
the active treatment was even larger at the 13-year examination than in the 
control group (0.4mm). This may be explained by the fact that all patients in the 
test group received SRP+PVP iodine treatment every third month. 
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Figure 7. Mean Probing pocket depth  
 
 
The effect of meticulous plaque control on pockets with a PPD of ?5 mm  but 
with various bone topography had an obvious clinical effect on pocket reduction 
only in those sites with a horizontal bone level whereas no such effects were 
observed at sites with  infrabony defects. However, it was found that surgical 
treatment irrespective of the bone morphology of the periodontal pockets 
resulted in the similar pocket reduction that was observed for suprabony pockets 
after professional delivered supragingival plaque control. Thus, the results 
indicate that periodontal surgery in infrabony/vertical defects may be more 
justified than for sites with only suprabony defects. Furthermore, topical 
application of minocycline in conjunction to surgery resulted in a minor 
additional pocket reduction of 0.3 mm.  
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Figure 8. Mean pocket reduction (mm) 
 
Meticulous supragingival plaque control combined with surgical/non-surgical 
therapy and additional antiseptics/antibiotics may be beneficial for patients with 
advanced periodontal disease although the mean additional effect is small. 
However, this minor adjunctive effect was observed in studies where the 
subjects had performed thorough plaque control and may not be considered to 
be decisive for the long term maintenance of the periodontal health of the 
patient. 
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